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Abstract 
The proteasome is a large protease in the cell that contributes to the controlled 
degradation of proteins. This 2.5MDa 26S proteasome complex consists of a 19S regulatory 
particle (RP) that recognizes substrates and a 20S proteolytic core particle (CP) that hydrolyses 
substrates. To function optimally all 66 subunits of the proteasome complex need to assemble 
properly. Efficient and accurate assembly of the proteasome is achieved with the help of proteins 
that can monitor the quality of the proteasome during pre- and post-assembly processes. The 
work in this thesis described an investigation into two of such quality control mechanisms. Pba1-
Pba2 dimer has been known to facilitate the CP assembly by interacting with the top of the α-
ring of CP throughout CP maturation. After CP maturation, RP utilizes same surface to form a 
CP-RP complex. Our data showed that Pba1-Pba2 binds tightly to the immature CP and prevents 
RP association. Once matured CP has a reduced affinity for Pba1-Pba2 and shows a higher 
affinity towards RP, resulting the formation of 26S proteasome complex. Our results imply that 
during maturation, CP undergoes conformational changes that results in this switch in affinity. 
Mathematical models indicate that during assembly such an ‘affinity switch’ quality control 
mechanism is required to prevent immature CP-RP complex formations. These types of wrong 
dead end products prevent efficient proteasome complex formation.    
Proteasomes formed with post-assembly defects are enriched with the proteasome 
associated protein Ecm29. Here Ecm29 is proposed to function as a quality control factor that 
inhibits such defective proteasomes to avoid aberrant protein degradation. This would require 
Ecm29 to preferably bind to mutant proteasomes. While we know Ecm29 interacts with RP as 
well as CP, we still don’t understand well how it binds to proteasomes holoenzyme. Here, we 
identify that besides the Rpt5 subunit of RP, Ecm29 binds to alpha7. We showed that conserved 
acidic residues containing unstructured C-terminal region of the CP subunit alpha7 facilitates the 
Ecm29-Proteasome interactions. Further mapping revealed the importance of phosphorylation of 
serine residues at the alpha7 C-terminal tail for Ecm29 interaction. We anticipate that this study 
leads to identification of specificity of the Ecm29 for the defective proteasomes. Overall this will 
help us to understand the role of Ecm29 in regulation of defective proteasomes in vivo. 
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Abstract 
The proteasome is a large protease in the cell that contributes to the controlled 
degradation of proteins. This 2.5MDa 26S proteasome complex consists of a 19S regulatory 
particle (RP) that recognizes substrates and a 20S proteolytic core particle (CP) that hydrolyses 
substrates. To function optimally all 66 subunits of the proteasome complex need to assemble 
properly. Efficient and accurate assembly of the proteasome is achieved with the help of proteins 
that can monitor the quality of the proteasome during pre- and post-assembly processes. The 
work in this thesis described an investigation into two of such quality control mechanisms. Pba1-
Pba2 dimer has been known to facilitate the CP assembly by interacting with the top of the α-
ring of CP throughout CP maturation. After CP maturation, RP utilizes same surface to form a 
CP-RP complex. Our data showed that Pba1-Pba2 binds tightly to the immature CP and prevents 
RP association. Once matured CP has a reduced affinity for Pba1-Pba2 and shows a higher 
affinity towards RP, resulting the formation of 26S proteasome complex. Our results imply that 
during maturation, CP undergoes conformational changes that results in this switch in affinity. 
Mathematical models indicate that during assembly such an ‘affinity switch’ quality control 
mechanism is required to prevent immature CP-RP complex formations. These types of wrong 
dead end products prevent efficient proteasome complex formation.    
Proteasomes formed with post-assembly defects are enriched with the proteasome 
associated protein Ecm29. Here Ecm29 is proposed to function as a quality control factor that 
inhibits such defective proteasomes to avoid aberrant protein degradation. This would require 
Ecm29 to preferably bind to mutant proteasomes. While we know Ecm29 interacts with RP as 
well as CP, we still don’t understand well how it binds to proteasomes holoenzyme. Here, we 
identify that besides the Rpt5 subunit of RP, Ecm29 binds to alpha7. We showed that conserved 
acidic residues containing unstructured C-terminal region of the CP subunit alpha7 facilitates the 
Ecm29-Proteasome interactions. Further mapping revealed the importance of phosphorylation of 
serine residues at the alpha7 C-terminal tail for Ecm29 interaction. We anticipate that this study 
leads to identification of specificity of the Ecm29 for the defective proteasomes. Overall this will 
help us to understand the role of Ecm29 in regulation of defective proteasomes in vivo. 
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Chapter 1 - Introduction 
Large multisubunit complexes and challenges in their biogenesis. 
Almost all cellular processes in the cell occur through protein-protein interactions. Most 
often these processes are either regulated through multi-protein cascades or though multi protein 
complexes. In multi-protein cascade pathways (e.g. blood coagulation), one step in the cascade is 
handled by the single protein at a time and then channeled to the next protein in the cascade via 
activation or via posttranslational modifications. Some of the crucial multistep processes in the 
cells however are accomplished by the protein complexes made of many subunits those either of 
one type (homomer) or different types (heteromer) of polypeptides (e.g. Spliceosome, Ribosome, 
Proteasome etc.).  Here, each subunit of the complex can either have distinct role or perform 
ancillary function in order to complete the cumulative task by particular multisubunit complex. 
Proper assembly of these multisubunit complexes is essential to maintain their optimal biological 
functions. Therefore steps in the assembly processes of most of these large multisubunit 
complexes are evolutionary conserved. This shows the preserved importance of multisubunit 
assembly in order to conserve the crucial signaling pathways that facilitates the regulation for 
cell survival1.  
Multisubunit complex assembly is a complicated process where many subunits have to 
come together in a precise order. Here specific surface areas of the different subunits will have to 
interact with each other to form the functional complex. Cell takes the help of auxiliary proteins 
called chaperones that assist in the efficient formation of the multisubunit complexes. Many 
assembly chaperones have been identified over the last few years are specific for the specific 
protein complex assembly2.  Unlike the well-known traditional chaperones, the assembly 
chaperones do not process nascent protein folding into tertiary structures and are not 
promiscuous in their substrate choice. Additionally, assembly chaperones contain a variety of 
protein-protein interacting domains. Hence, these chaperones are associated with the precursor 
subunits and subcomplexes during assembly process to guide them for interaction with other 
subcomplexes. For example, Ribosome assembly in yeast involves more than 200 assembly 
factors and approximately 79 small nuclear RNAs to assist in the ribosome assembly process3. 
Similarly spliceosome requires seven ‘sm’ proteins to assist in the processing and arrangement of 
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snRNPs to form spliceosome4. Likewise, proteasome a protein degradation complex also takes 
help of ten chaperones to assemble into functional complex5,6. Most often chaperones are not 
part of the final assembled product, hence they are timely released during assembly process.  In 
addition, recently it has been shown that many of these chaperones are involved in avoiding 
nonspecific premature assembly formations and perform a type of a quality control function7,8.  
Despite being identified for their importance in the assembly, the detailed mechanisms of 
function of many of these chaperones is still under investigation and certainly lack the clear 
understanding.  
Proteasome: protein-degrading large multisubunit complex.  
The work in this thesis is specifically focused on the assembly of the large protein 
degrading protease complex, proteasome. The typical 26S proteasome in yeast is a ~ 2500 kDa 
complex that is made up of two 19S regulatory particles (RP) and 20S core particle (CP). RP 
recognizes ubiquitinated protein substrates, deubiquitinate and unfold them into polypeptide 
form. Once unfolded, substrate is then translocated to the core particle. CP is a cylindrical-
shaped structure that hydrolyzes the protein substrates into short peptides (Fig 1.1).  
Figure 1.1 Proteasome and its subunits arrangements. 
 
Arrangement of subunits in the typical 26S proteasome complex. Regulatory particle (RP) 
consists of base that is formed by six Rpt and two Rpn subunits and lid that is formed by 11 Rpn 
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subunits. Core particle (CP) consists of four rings.  Out of these, outer two are α-rings and 
central two are β-rings each made up of seven subunits. Three of the seven β subunits namely β1 
β2 and β5 has proteolytic activity. β-rings are sandwiched between two α-rings that made up of 
seven α subunits in each rings9. 
The RP has in total 19 subunits that are distributed over two subcomplexes, the base and 
the lid. The base contains six are AAA-ATPase subunits called Rpts (Rpt1 to Rpt6) and two 
largest non-ATPase subunits (Rpn1 and Rpn2). The other ten non-ATPase subunits (Rpn3, Rpn5 
to Rpn13) are part of the lid subcomplex. Further, CP is made of four stacked rings with an 
arrangements of α1-7β1-7β1-7α1-7. There are two outer α-rings in the CP, each made up of seven α 
subunits (α1 to α7). Middle two β-rings are also made up of seven subunits (β1 to β7) each.  RP 
through its base subunits is directly associated with the α-ring on both sides of the CP.  Overall 
the proteasome complex is assembled by putting in total 66 subunits together10. 
Protein substrate that needs to be degraded through proteasome are first tagged with the 
small 76 amino acid protein, ubiquitin. Ubiquitin tag on the substrate is added through Ub-
activating (E1), Ub-conjugating (E2), and Ub-ligating (E3) enzyme cascade of UPS pathway. 
Although it is now well known that ubiquitin is not the sole warrant for degradation and 
ubiquitin-independent proteasomal degradation has also been observed for many substrates11-14. 
Substrates that get ubiquitin tag are then recognized by the Rpn10 and Rpn13 subunits from RP. 
Prior to degradation the ubiquitin is recycled as it is removed through deubiquitinated by Rpn11 
subunit. Ubiquitin molecules are then recycled for tagging onto the new protein substrate. The 
deubiquitinated substrate is then unfolded by the Rpt subunits though an ATP dependent process 
and translocated into the core particle through the α-ring that has the narrow substrate entry gate 
formed with the N-terminal ends of the α subunits.  Once translocated substrate reaches to the β-
ring, here three β subunits namely β1, β2 and β5 those having post-acidic, tryptic, and 
chymotryptic activity respectively hydrolyzes protein into small peptides and peptides are then 
released from the proteasome. Overall the optimal protein hydrolysis by the proteasome demands 
proper functioning of all the components of the proteasome complex. One way to achieve this by 
assuring the efficient and precise formation of the proteasome holoenzyme complex. 
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Proteasome activity and diseases 
Improper assembly of the complex can compromise the activity of the proteasome. This 
generally leads to either accumulation of aberrant or unwanted proteins or untimely degradation 
of essential proteins from the cell resulting into disturbed protein homeostasis.  Many disease 
conditions have been reported where proteasome activity is either reduced or enhanced compared 
to its normal activity15,16. The table 1.1 below summarizes some of these diseases.  
Table 1.1 Diseases and the proteasome activity (modified from15) 
 
Due to its direct or indirect involvement in many diseases including cancers and 
neurodegenerative diseases; proteasome in recent years has become a favorable target for the 
drug discovery. Over the last decade several molecules have been screened that can act as a 
proteasome inhibitors. Currently, FDA approved boronate derived molecule Bortezomib (brand 
name: Velcade) and epoxyketone derived proteasome inhibitor molecule carfilzomib (Kyprolis) 
are used for the treatment of cancer patients17. In recent studies, ixazomib (MLN9708) has been 
demonstrated as an effective reversible oral proteasome inhibitor that has now reached into 
Phase III trials18.  
Since several key proteins in crucial signaling pathways in the cells are regulated though 
proteasome; inhibiting proteasome has shown to have severe side effects and hence 
combinational therapies are required in the treatments19. Moreover studies reporting increased 
Disease proteasomes activity Proteasome population affected 
Cardiac dysfunction 
- transient ischemia 
- pressure overload 
 
decreased activity 
decreased activity 
 
26S proteasomes 
26S proteasomes 
Neurodegenerative 
- Alzheimer's 
- Parkinson's 
- amyotrophic lateral sclerosis 
- Huntington's 
 
decreased activity 
decreased activity 
decreased activity 
decreased activity 
 
20S/26S proteasomes 
20S/26S proteasomes 
20S/26S proteasomes 
20S/26S proteasomes, 
Cancer 
- multiple myeloma 
- renal carcinoma 
 
increased activity, 
depressed expression 
 
20S/26S proteasomes, 
immunoproteasomes 
Cachexia 
- sepsis 
- metabolic acidosis 
 
increased activity 
increased activity 
 
20S/26S proteasomes 
20S/26S proteasomes 
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resistance to these proteasome inhibitors in cancer patients are not uncommon20-23. This demands 
the development of alternate strategies to regulate the proteasome activity in disease conditions 
rather than its inhibition. One way the proteasome activity can be modulated is by regulating the 
proteasome formation in the cell. Hence, improving our knowledge on the proteasome assembly 
will certainly help in identifying new specific targets that can be altered to control the 
proteasome activity specific to the diseases conditions.   
Proteasome assembly and assembly chaperones.  
Over the last couple of decades tremendous efforts there have been focused on elucidate 
the understanding of proteasome assembly. Biochemical and genetic analysis of proteasome 
assembly lead to rapid advancement in identification and characterization of proteins called 
chaperones that are specific for proteasome assembly. Ten different chaperones have been 
identified that contribute towards efficient proteasome formation but their timely role in the 
assembly pathway is not yet clearly understood9. In addition, new proteins are being identified 
that can function as proteasome chaperones indicating the complexity in regulation of 
proteasome assembly24. Most importantly these assembly chaperones are evolutionary conserved 
from lower to higher eukaryotes as with proteasome subunits suggesting they have functional 
significance in the cell. Hence, detailed understanding of these chaperones functions is necessary 
as it directly affects the proteasome complex formation and might ultimately have impact on the 
functionality of the proteasome.  
Table 1.2 Chaperones for the proteasome assembly 
 
  
 
Proteasome Subcomplex Chaperones (Human orthologue) 
Regulatory Particle 
(RP) 
Hsm3 (S5b) 
Nas2 (p27/Bridge-1) 
Nas6 (Gankyrin) 
Rpn14 (PAAF1) 
Adc17 
Core Particle 
(CP) 
Pba1 (PAC1 or PSMG1) 
Pba2 (PAC2 or PSMG2) 
Pba3 (PAC3 or PSMG3) 
Pba4 (PAC4 or PSMG4) 
Ump1 (POMP) 
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Proteasome assembly chaperones can be divided into two groups - RP assembly 
chaperones and CP assembly chaperones; due to their specificity for the assembly of particular 
subcomplexes.  Table 1.2 above listed chaperones identified till now for the proteasome 
assembly with their human orthologue shown in bracket.   
RP assembly and Chaperones 
How cells precisely assembles an asymmetrical heterogeneous structure of 19S 
regulatory particle was a long standing question until last decade. The RP assembly is a 
complicated task since RP subunits contains varied domain structures that makes them 
structurally different25. Hence, the spontaneous assembly of all the subunits together to form 
base and lid can be ruled out and certainly needs help from the chaperone.  
Although assembly chaperones specific for the lid assembly has yet to be identified, 
different assembly modules have been presented for its assembly. Biochemical and mass 
spectrometric approaches have been used to identification of lid intermediates formed when one 
or more Rpn subunits are mutated from yeasts. The current model for lid formation includes 
interaction between subcomplexes containing Rpn5, 6, 8, 9, and 11 as one module and Rpn3, 
Rpn7, and Sem1 as another26, 27. The Rpn12 incorporation seems to join the assembly in the last 
stage and complete the lid assembly28. The improper interaction between the subunits of these 
modules or formation of wrong lid subcomplex intermediate or no incorporation of Rpn12 can 
hinder the lid formation28. This strongly indicates this process must be associated with the 
chaperones that help in promoting the precise lid formation and elimination of misassembled lid 
components through some quality control process29.  
In comparison to the lid assembly, formation of base that contains six AAA ATPases has 
been well studied and five assembly chaperones have been identified those are evolutionary 
conserved from yeast to human (Table 1.2). In yeast Hsm3 (human orthologue: S5b), Nas2 
(p27), Nas6 (Gankyrin), Rpn14 (PAAF1) and recently reported Adc17 are known to function as 
base assembly chaperones.  Although, RP chaperones require C-domain of the Rpt subunits for 
their interaction; the analysis of at least former four chaperones showed great variation among 
each other in terms of their structures6,9,24. This suggests that base assembly is highly coordinated 
by maintaining specificity between Rpt subunit and particular RP chaperone that it binds to. 
7 
Specifically, Hsm3 interacts with the C-domain of Rpt1, Nas2 binds to Rpt5 C-domain, Nas6 
that of Rpt3, and Rpt6 C-domain interacts with Rpn14. Similar to lid assembly, base assembly 
intermediates have also been observed in biochemical and structural studies of these chaperones. 
These intermediates are formed by one or more Rpt subunits and are associated with RP 
chaperones. Deletion of these chaperones affects the efficiency of the proteasome formation 
highlighting its importance6.  
RP assembly can happen by two possible means. First, base subunits can form a specific 
heterodimers (Rpt1-Rpt2, Rpt3-Rpt6, and Rpt4-Rpt5) along with their chaperones. These dimers 
are then assembled onto the CP by docking their C-terminal tail into pockets on α-ring surface. 
Since chaperones are bound with assembly intermediates at the C-domain, there will be a steric 
interference for the RP to dock onto CP and hence this seems very unlikely. Second most 
accepted RP assembly pathway proposes removal of all the chaperones after formation of 
complete ATPase hexameric ring and then docking the ATPase ring onto α-ring surface of the 
CP. However the timely removal of the RP chaperones during ATPase ring formation is still not 
well understood. Once Base-CP are formed then lid is assembled using it as a platform30.   
CP assembly and Chaperones 
Core particle made up of four rings each containing seven subunits is assembled with the 
help of five chaperones (Pba1, Pba2, Pba3, Pba4 and Ump1). Pba chaperones work in pairs and 
form heterodimers as Pba1-Pba2 and Pba3-Pba4. Core particle assembly starts with formation of 
α-ring where Pba1-Pba2 and Pba3-Pba4 nucleates the assembly process (Fig 1.2). Pba1-Pba2 are 
present on the outer side of the α-ring and hence proposed to prevent the α-ring dimerization. 
Pba3-4 are attached to other side of the α-ring where β-ring assembles, and hence Pba3-Pba4 has 
to be displaced from the α-ring before β4 subunit is incorporated to avoid steric clash31. Three β 
subunits (β1, β2, β5) those having catalytic sites are incorporated in inactive forms containing 
pro-peptide. Ump1 is a mostly unstructured protein that promotes the formation of precursor 
complexes of CP. Assembly intermediate containing heptameric α-ring together with partial β-
ring (β1 to β6 subunits) and three chaperones (Pba1-Pba2 and Ump1) formed during core 
particle assembly is called 15S or immature core particle.  During CP maturation process, two 
such immature core particles come together, β7 subunit is incorporated, and proteolytic subunits 
are activated by pro-peptide auto-cleavage and forms the four ringed mature core particle. Ump1 
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that is trapped inside CP after CP maturation, becomes its first substrate and gets degraded. 
During CP assembly, Pba1 and Pba2 are the last chaperones released from the mature CP 
complex. Other than β subunit arrangement, Ump1 is also required for their pro-peptide cleavage 
since deletion of Ump1 causes CP formation that is not completely matured32. Since chaperones 
guide the assembly and help in stabilization of the assembly intermediated, deletion of these 
chaperones have impact on the complex formations and hence they carry out the important 
quality control function during the assembly process.  
Figure 1.2 Stages in core particle (CP) assembly 
 
 
Proteasome assembly: α1 to α7 subunits comes together with the help of Pba1-Pba2 and Pba3-
Pba4 and forms the heptameric ring. Ump1 assist in assembly of the β-ring which has β1 to β6 
subunits, Pba3-Pba4 is released during β-ring formation. Immature core particle formed has 
Pba1-Pba2 dimer on the α-ring, catalytic β subunits have pro-peptides and hence it does not 
have proteolytic activity.  Two immature core particle joins together to form mature core 
particle where ump1 is degrade, Pba1-Pba2 are released, catalytic subunits becomes active and 
RP associated with the mature CP to form complete 26S proteasome.  
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Proteasome associate proteins: 
Besides the proteasome subunits and assembly chaperones, additional proteins have been 
identified that associated with the proteasome. The interaction of most of the proteasome 
associated proteins is salt labile. Hence, to study these proteins the proteasome purification needs 
to be done under low salt conditions. These proteins are different from the assembly chaperones 
because they do not promote the assembly process. Instead, they interact with the assembled 
proteasome or proteasome subcomplexes and can modulate the proteasomal activity. These 
proteins perform variety of functions and hence they are part of the ubiquitin proteasome 
system33.  
Work in this thesis is focused on one of the proteasome associated protein called Ecm29. 
This 210 kDa elongated curved protein contains total 29 HEAT repeat domains and conserved in 
human (KIAA0368)34,35. Previous work on Ecm29 has shown that it binds to the assembled 
proteasomes 36. Absence of ATP during proteasome purification from ecm29Δ strains results into 
dissociation of proteasome as CP and RP. Ecm29 has observed to be enriched on the proteasome 
in the absence of nucleotide and function to stabilize the complex37,38. Mutations in proteasome 
subunits or mutations in the proteasome chaperones that result into defective proteasome 
complex formations also have higher level of Ecm2939,40. Here, Ecm29 functions as a quality 
control factor that binds to such defective proteasomes and inhibits their ATPase activity. This 
mechanism of proteasome activity inhibition is crucial in order to avoid the aberrant protein 
degradation through mutant proteasomes.        
Quality control in proteasome assembly 
The variety of assembly intermediate modules formed during proteasome assembly are 
part of the quality control process that makes sure proper interactions between subunits as well 
as between intermediate subcomplexes are maintained and miss-assembly is prevented. 
Chaperones play an important role in the assembly process by their interactions with these 
modules and avoid the premature interactions. If such interactions happen as a result of 
mutations in proteasome subunits, mutations in assembly chaperones, or under stress conditions 
then proteasome assembly can go wrong and can form the misassembled proteasome. These 
proteasomes can be regulated by the Ecm29. Overall there is a pre-assembly as well post-
assembly quality control mechanism is involved. The work reported in this thesis describes the 
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detailed investigation on two of such quality control mechanisms. We identified the new role of 
Pba1-Pba2 chaperones in a pre-assembly quality control during CP assembly. We also expanded 
our knowledge about post-assembly quality control mechanism by understanding interactions of 
Ecm29 with the assembled proteasome.    
Pre-assembly quality control mechanism 
Studies with RP chaperones Hsm3 and Nas2 have shown that in addition to help in Rpt 
ring formation it also prevent interaction of base intermediates with CP. C-terminal tail of the 
Rpt subunits dock into the pocket formed between two α subunits41. Interaction of RP 
chaperones to the same site on Rpt subunits during base assembly restrict docking of the RP 
assembly intermediates onto the CP and hence prevent formation of immature complex 
formations6. While the role of the RP chaperones in regulating the RP-CP association has been 
established; mechanistic understanding still awaits detailed biochemical experimentations.  
Analysis of the CP chaperones have mainly focused for the role in the CP assembly. Two 
CP chaperones Pba1 and Pba2 have been identified in 2005 and several functions have been 
proposed42. Besides nucleating the formation of the α-ring, Pba1-Pba2 have been proposed to 
prevent α-ring dimerization. Furthermore, these chaperones might function to ensure “quality 
control” during the CP assembly31. However, the biochemical evidence supporting these 
functions is missing. Pba1-Pba2 are bound to the face of the CP cylinder and are released at the 
last stage in the CP assembly. We hypothesized Pba1-Pba2 also can regulate the association of 
CP with the RP during CP assembly process. Chapter-2 in this thesis describes our biochemical 
analysis of Pba1-Pba2 interactions with CP during CP maturation. By purifying CP assembly 
intermediate 15S immature CP in the presence and absence of Pba1-Pba2 we showed that Pba1-
Pba2 interaction with the immature CP is necessary to prevent early association of RP with 
immature CP. Pba1-Pba2 in this case shows strong affinity for immature CP and loses its affinity 
for CP after CP maturation. RP on the other hand shows weak affinity for the immature CP and 
strong affinity for the mature CP. Conversely, RP shows weak affinity to immature CP and 
strong affinity for mature CP easily displacing Pba1-Pba2 from mature CP. Additionally we 
identified that the strong affinity interaction of Pba1-Pba2 with immature CP is contributed 
through the C-terminal tail Hb-Y-X motif of Pba2. These results implied that CP undergoes a 
conformational change during its maturation that results into the affinity switch.  Further our 
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mathematical modeling studies suggest that this type quality control mechanism of affinity 
switch during CP assembly is necessary in order to prevent formation of wrong subcomplex 
assembly intermediates that cannot proceeds into the efficient proteasome formation.  
Post-assembly quality control mechanism 
Assistance of assembly chaperones and regulation through pre-assembly quality control 
mechanism aid the proper and efficient proteasome formation. However defective proteasome 
formation still occurs in the cell either during physiological stress conditions or due to the 
mutations in either chaperones or proteasome subunits itself. Cell has evolved a mechanism to 
recognize such mutant proteasomes after proteasome assembly.  
Chapter-3 in the thesis describes the post-assembly quality control mechanism in the 
proteasome that involves Ecm29. How Ecm29 recognizes mutant proteasome specifically over 
the normal proteasome is still unclear. To understand how Ecm29 recognizes mutant 
proteasomes, we first need to identify the Ecm29 interaction sites onto the RP as well CP of the 
proteasome. Previous data from our lab showed that Ecm29 interacts with the RP though its Rpt5 
subunits. Our current biochemical studies reported in chapter 3 led us to the identification of 
Ecm29 interaction site on CP. We showed that Ecm29 binds to the α7 subunit of core particle. 
We further map the interaction sites on α7 and demonstrated that structurally unresolved C-
terminal tail of the CP is important for Ecm29 interaction with the proteasome. The α7 C-
terminal tail has conserved consecutive acidic residues and three serine phosphorylation sites. 
Proteasome purified from α7 phosphomutants of these serine residues confirms that Ecm29 
binding to proteasome required α7 phosphorylation at C-terminal tail. Further, the α7 C-terminal 
tail is important in vivo as it rescues the phenotype observed from mutant proteasomes.  
Overall elucidating the pre-assembly and post-assembly quality control mechanisms of 
proteasome formation improve our knowledge in regulation of proteasome in the cell in vivo. In 
a broader aspect, identification of key regulatory steps will help in the future for drug discovery 
that can modulate the proteasome activity by controlling dynamics of proteasome formation in 
disease conditions rather than its complete inhibition.   
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 Abstract 
Proteasome assembly is a complex process, requiring 66 subunits distributed over several 
subcomplexes to associate in a coordinated fashion. Ten proteasome-specific chaperones have 
been identified that assist in this process. For two of these, the Pba1-Pba2 dimer, it is well 
established that they only bind immature core particles (CPs) in vivo. In contrast, the regulatory 
particle (RP) utilizes the same binding surface but only interacts with the mature CP in vivo. It is 
unclear how these binding events are regulated. Here, we show that Pba1-Pba2 binds tightly to 
the immature CP, preventing RP binding. Changes in the CP that occur on maturation 
significantly reduce its affinity for Pba1-Pba2, enabling the RP to displace the chaperone. 
Mathematical modelling indicates that this ‘affinity switch’ mechanism has likely evolved to 
improve assembly efficiency by preventing the accumulation of stable, non-productive 
intermediates. Our work thus provides mechanistic insights into a crucial step in proteasome 
biogenesis. 
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 Introduction 
The selective and timely degradation of polypeptide chains in the cell is important for 
overall protein homeostasis as well as an integral part of many cellular processes. Many proteins 
destined for degradation undergo a modification where ubiquitin is covalently attached to lysine 
residues. The ubiquitin-tag targets substrates to the proteasome, where they are deubiquitinated, 
unfolded, and hydrolyzed into short peptide fragments. The proteasome itself is a complex 
molecular machine, containing 66 subunits that must assemble into a 2.5 MDa complex. The 
subunits are broadly organized into a regulatory particle (RP or 19S, also called PA700 in 
mammals) that is responsible for substrate recognition, deubiquitination, and unfolding, and a 
proteolytically active core particle (CP or 20S)1. The CP is formed by four stacked rings, each 
consisting of seven unique α-subunits or seven unique β-subunits, in an α1-7 β1-7 β1-7 α1-7 
arrangement. During CP maturation, the β1 (Pre3), β2 (Pup1), and β5 (Pre2) subunits become 
proteolytically active through an autocatalytic process that removes propeptides present within 
these subunits. This occurs when two half CPs, often referred to as 15S or immature CP, 
dimerize. In yeast, five assembly chaperones, Ump1, Pba1 (also called Poc1), Add66 (also called 
Pba2 or Poc2), Irc25 (also called Pba3, POC3, or DMP2), and Poc4 (also called Pba4 or Dmp1) 
have been found to bind the CP prior to its maturation (reviewed in 2). Here, we will refer to 
these factors as Ump1 and Pba1 to Pba4. Each of these has a human ortholog, known as POMP, 
and PSMG1 to PSMG4 (also called PAC1 to PAC4).  Pba3 and Pba4 form a dimer that binds to 
α5 (Pup2) and promotes proper α-ring assembly3-5. The Pba3-Pba4 dimer must dissociate before 
the β4 (Pre1) subunit can join the complex due to extensive steric clashes with this subunit4. The 
chaperone Ump1 associates with immature CP after the α-ring forms. Upon dimerization of half 
CPs, Ump1 is retained inside the CP and is degraded as part of the maturation process6. Pba1 and 
Pba2 form a dimer that, like Ump1, is present on the half CP, but binds on the outside of the CP 
cylinder base7,8. Although Pba1-Pba2 has been shown to prevent α-ring dimerization in 
mammals9, its cellular functions remain poorly characterized.  
While the CP can be found in the cell by itself (a.k.a. the free CP), in most cases it acts in 
consortium with a set of associated factors10,11. In yeast the RP, Blm10, and Pba1-Pba2 can all 
bind to the ends of the CP cylinder, although the later has only been shown to bind mature CP in 
vitro8,12-14. Blm10 (PSME4/PA200 in humans) has been proposed to function in CP 
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maturation15,16, CP localization17, and activation of protein degradation18-20. In recent years it has 
become clear that these interaction partners all utilize a similar mechanism where C-terminal 
tails dock into pockets located at the interface between CP α-subunits, often facilitated by a 
conserved C-terminal HbYX-motif8,12,19,21-24. The C-terminal tail of Pba1 docks into the α5-α6 
(Pup2-Pre5) pocket and the Pba2 tail in the α6-α7 (Pre5-Pre10) pocket8. Interestingly, the α5-α6 
pocket is also utilized by Blm10 and the RP subunits Rpt1 and Rpt5, while the α6-α7 pocket can 
associate with Rpt4 and Rpt512-14,24. This suggests that the RP, Blm10, and Pba1-Pba2 compete 
with one another for CP binding.  
Since the full α-ring forms early in assembly, one would expect a priori that any CP 
binding partner would interact with both mature and immature CPs.  While Blm10 can indeed 
associate with both forms of the CP, the RP is only found associated with mature particles, and 
Pba1-Pba2 only binds immature CP in vivo9,16,25-27. These observations imply that the binding of 
these factors to the CP is tightly regulated. The RP chaperones Nas2, Nas6, Hsm3, and Rpn14 
(known in humans as PSMD9/p27, PSMD10/gankyrin, PSMD5/S5b, and PAAF1/Rpn14 
respectively) are one example of this regulation: they all have the capacity to interfere with the 
association of immature RP subcomplexes and the CP28-34. Despite intense research over the last 
decade, however, surprisingly little is known about the mechanisms that control the interaction 
between the CP and its binding partners. 
In this work, we demonstrate that the Pba1-Pba2 dimer associates tightly with immature 
CP and prevents them from associating with the RP. Upon CP maturation, however, the affinity 
of Pba1-Pba2 for the CP changes dramatically, presumably due to a subtle conformational 
change in the α-ring that impacts the Pba1-Pba2 binding surface. Consistent with this we 
observed that the Pba2 tail, which plays a negligible role in mature CP binding, contributes 
substantially to immature CP binding. Mathematical models of proteasome assembly 
demonstrated that this “affinity switch” is crucial for achieving high yields of functional 
molecules. Finally, our results reveal that Pba1-Pba2 is also required for efficient incorporation 
of α5 and α6 into the immature CP. 
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 Experimental Procedures 
 Yeast techniques and reagents  
Yeast strains used are summarized in Table 2.1. Genomic manipulation of yeast was done 
using a PCR based approach50,51.  Upon transformation of yeast, successful integration was 
confirmed by positive PCR for integration and negative PCR for wildtype. Pba1 knockout primer 
pRL 252 (5’-AAG ATA TCA TCG CAC TAC AGT AAA ATT TTC ATT TAT AGC GCG 
GAT CCC CGG GTT AAT TAA-3’) and pRL253 (5’-CTC TTT CAC TCG CCA TTA CTG 
ACA TTC TGT GAT CGC CAT CAT CGA TGA ATT CGA GCT CGT-3’) and Pba2 knockout 
primers pRL254 (5’-ACT TCA GGA AAG AAT AGC ACA AAA CCC AAA GGA ACA TAC 
GCG GAT CCC CGG GTT AAT TAA-3’) and pRL255 (5’-TAT ATG CAC TTG TAT AGA 
AAA CAG ATA TAC TTC TCG GTT CAT CGA TGA ATT CGA GCT CGT-3’) were used 
together with templates pAG25 (natMX4) and pAG32 (hphMX4)51 in a PCR to prepare DNA for 
yeast transformation. To create a strain deleted for Blm10, smash and grab prepared genomic 
DNA from a strain where the Blm10 ORF was replaced with ClonNAT selection cassette27 was 
used as template for PCR with the following primers: pf2Blm10 (5’-CTG TCA TCA GGG CTT 
G-3’) and pr2Blm10 (5’-GTT GAT CAT TCT CAG TGG-3’). To produce C-terminal truncation 
of Pba1 that deleted the codons coding for the last three amino acids of Pba1, pba1-ΔCT3, 
primers pRL210 (5’-TGG AGG TGT GAT AGC GCG GCA ATT GGT GCA CAA TCA GGC 
TGA GGC GCG CCA CTT CT-3’) and pRL253 (5’-CTC TTT CAC TCG CCA TTA CTG ACA 
TTC TGT GAT CGC CAT CAT CGA TGA ATT CGA GCT CGT-3’) were used with pFA6a-
3HA-kanMX6 as template50.  To create pba2-ΔCT3 primers pRL211 (5’-GCA TAC GGA ATG 
GCG GAT GCA AGA GAT AAA TTT GTA GAT TGA GGC GCG CCA CTT-3’) and pRL255 
(5’-TAT ATG CAC TTG TAT AGA AAA CAG ATA TAC TTC TCG GTT CAT CGA TGA 
ATT CGA GCT CGT-3’) were used with pFA6a-3HA-TRP1 as template50. Integrations were 
confirmed by PCR and sequencing. To create a strain with C-terminal YFP tag fused to β2 we 
used a knock-in DNA fragment synthesized from pDH6 as template (a generous gift of the Yeast 
Resource Center) in a PCR with primers pRL73 (5’-AAT ATT TGT GAC ATA CAA GAA 
GAA CAA GTC GAT ATA ACG GCT GGT CGA CGG ATC CCC GGG -3’) and pRL74 (5’-
TGA TTT ACT ATA CTA AAA TAT ACT TAA GTT CTA TGT TTT ACT ATC GAT GAA 
TTC GAG CTC G -3’). Gibson cloning kit (NEB) was used to create a CEN plasmid that 
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expresses His-Myc Pba2 utilizing the promoter and terminator of PBA2. pRS416 was digested 
with BamHI and mixed with two PCR products that were generated using yeast gDNA as 
template together with the following primer pairs: pRL274 (5’-TGC AGC CCG GGG GAG TCC 
TCG ATT TGA CTG GAA AC-3’) with pRL275 (5’-CAG ATC TTC CTC GCT AAT CAG 
CTT CTG CTC CAT CGT ATG TTC CTT TGG GTT TTG TGC-3’) and pRL276 (5’-GAG 
GAA GAT CTG CAC CAC CAT CAC CAT CAC CAT GGA AGC AGC TGC CTG GTG TTG 
CC-3’) with pRL277 (5’-CGC TCT AGA ACT AGT GAA ATT CAA AGA GAT GTT ACA 
GAC-3’) using the manufacturers protocol. The resulting plasmid is pCEN-His-Myc-Pba2 
(pJR643). 
 Antibodies 
A polyclonal antibody that recognizes the Pba1-Pba2 complex was generated using a 
standard immunization protocol (Rockland Immunochemicals, Inc.) with a dimer of Pba1 and 
His-tagged Pba2 purified from E.coli as the antigen (see Appendix Figure A.1). Ecm29 and 
Rpn5 were detected using polyclonal antibodies kindly provided by Dr. Dan Finley (Harvard 
Medical School, Boston, MA). Monoclonal antibodies for α7 and Rpt5 were kindly provided by 
Dr. William Tansey (Vanderbilt-Ingram Cancer Center, Nashville, TN). Polyclonal anti-pup1 
(β2) antibody was a generous gift from Dr. R. Jürgen Dohmen (University of Cologne, Cologne, 
Germany). Antibodies recognizing Rpt1 and Blm10 were purchased from ENZO life sciences 
and THETM HIS-tag antibody was obtained from GenScript. Peroxidase-conjugated secondary 
antibodies were purchased from Jackson Immunoresearch Laboratories and for Fig. 2.2F Rabbit 
TrueBlot® IgG HRP from Rockland Immunochemicals was used. Anti-Myc antibody (9E10) 
was derived from an atcc hybridoma cell line (#CRL1729). The monoclonal anti-pgk-1 antibody 
was purchased from life technologies (#459250). All antibodies were used in 1:000 dilutions in 
TBST, except those against pgk-1 (1:10,000), Pba1-Pba2 (1:500), Myc (1:5), and Rpt5 (1:5,000). 
Uncropped images from the most important immunoblots are provided as Supplementary Figure 
5 in online version of the journal article. 
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Table 2.1 Yeast strains used for results in chapter-2 
Strain * Genotype Figure Ref. 
sUB61 A  MAT α lys2-801 leu2-3, 2-112 ura3-52 his3-
Δ200 trp1-1 
A.2A-B (2) 
sDL135 A MAT α pre1::PRE1-TEVProA(HIS3) 2.1A-D, 2.3A-B, 
2.3E, 2.4C, A.1A, 
A.2A, A.2C-D, 
A.4B. 
(3) 
sDL133 A MAT α rpn11::RPN11-TEVPro(HIS3) 2.3B. (4) 
SY36 A MAT α rpt1::HIS3, ProA-TEV-RPT1 in pEL36 
(TRP) 
A.2C-D. (3) 
Ump1Tap B MAT A ump1::UMP1- CBP-TEV-ZZ-
(His3MX6) 
2.1C-D, 2.3C, 
2.4A, 2.4C, A.1C, 
A.2C-D, A.4. 
(5) 
sJR789 A MAT A pba1::NAT pre1::PRE1-TEVProA(HIS3) A.1A. (a) 
sJR790 A MAT A pba2::HYG pre1::PRE1-
TEVProA(HIS3) 
A.1A. (a) 
sJR601 A MAT α pba1::HYG pba2::NAT 2.2B (a) 
sJR605 A MAT A  pba1:: HYG pba2::NAT pre1::PRE1-
TEVProA(HIS3) 
2.1A-B, A.1A. (a) 
sJR791 A MAT A blm10::NAT rpn11::RPN11-
TEVProA(HIS3) 
A.1A. (a) 
sJR792 B MAT A pba1::NAT ump1::UMP1- CBP-TEV-
ZZ-(His3MX6) 
2.1C, 2.4C, A.1C. (a) 
sJR793 B MAT A pba1::HYG blm10::NAT ump1::UMP1- 
CBP-TEV-ZZ-(His3MX6) 
2.1C-D, 2.3D, 
A.1C. 
(a) 
sJR794 B MAT A blm10::NAT ump1::UMP1- CBP-TEV-
ZZ-(His3MX6) 
A.1C. (a) 
sJR795 B MAT A pba1::PBA1ΔCT3 (KAN) ump1::UMP1- 
CBP-TEV-ZZ-(His3MX6) 
2.3F. (a) 
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sJR782 B MAT A pba2::PBA2ΔCT3 (KAN) ump1::UMP1- 
CBP-TEV-ZZ-(His3MX6) 
2.3F. (a) 
sJR809 B MAT A pba1::PBA1ΔCT3 (KAN) 
pba2::PBA2ΔCT3 ump1::UMP1- CBP-TEV-ZZ-
(His3MX6) 
2.3F. (a) 
sJR797 A MAT α pup1::PUP1-YFP (KAN) pre1::PRE1-
TEVProA(HIS3) 
2.3B, A.2B. (a) 
sJR852 A MAT A  pba2::NAT 2.2B (a) 
sJR853 A MAT A  pba2::NAT HIS-MYC-PBA2(URA) 2.2C (a) 
sJR857 A MAT α  pba1::HYG 2.2B (a) 
*All “A” strains have background genotype (lys2-801 leu2-3, 2-112 ura3-52 his3-Δ200 trp1-1) 
 All “B” strains have BY4741 background genotype (MAT A his3∆0 leu2∆0 met15∆0 ura3∆0). 
(a) This Study 
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Proteasome purification 
The purification of proteasomes and proteasome subcomplexes from yeast were in 
essence performed as described previously29-31,38. Specific yeast strains were grown overnight in 
2 to 3 liters of YPD media (final A600 ~ 10.0). Cells were collected and washed with H2O. 
Pellets were resuspended in 1.5 pellet volume of lysis buffer (50 mM Tris [pH8.0], 5 mM 
MgCl2, 1 mM EDTA, 1 mM ATP) and lyzed by French press (1200 Psi.). Lysates were cleared 
by centrifugation (10,000g for 30mins) and supernatant was filtered through cheesecloth prior to 
incubation with IgG beads (MP Biomedical; 0.75 ml resin bed volume per 25 gram of cell 
pellet). After 1 hour of incubation (rotating at 4 ºC), IgG beads were collected in an Econo 
Column (Bio-Rad) and washed with 50 bed volumes of ice-cold wash buffer (50 mM Tris [pH 
7.5], 5 mM MgCl2, 100 mM NaCl, 1 mM EDTA, 1 mM ATP). Next, material was washed with 
15 bed volumes of cleavage buffer (50 mM Tris [pH 7.5], 5 mM MgCl2, 1 mM DTT, 1 mM 
ATP). Bead-bound proteasome complex was either directly analyzed by loading on the SDS-
PAGE after boiling with equal amount of 2X SDS PAGE sample buffer or eluted by incubation 
with His-Tev protease (Invitrogen). Protease was removed by incubation with talon resin prior to 
concentrating the proteasome complexes using 100-kDa concentrator (PALL Life Sciences). 
Proteasome purifications were used directly or stored at -80 ºC in the presence of 5% glycerol.  
 Reconstitution assay 
Proteasome core particles and regulatory particles were purified as described previously38 
using strain sJR797 and SY36 respectively. 12.5 nM of CP and 62.5 nM of purified Pba1-Pba2 
dimer protein were reconstituted in reconstitution buffer (50 mM Tris‐HCl [pH 7.5], 5 mM 
MgCl2, 1 mM ATP, 50 mM NaCl, 10% glycerol)  (Appendix Figure A.2) and incubated for 30 
minutes at 30 ºC. Next, increasing amounts of RP were added to different tubes (0 nM, 1.25 nM, 
2.5 nM, 6.25 nM, 12.5 nM, 25 nM in reconstitution buffer), and the volume was adjusted to 20 
μl for all samples. Samples were incubated for 30 minutes at 30 ºC. To analyze the reconstitution 
assay, 1/10 volume of native gel loading buffer (50 mM Tris‐HCl [pH 7.4], 50% glycerol, 60 ng 
ml-1 xylene cyanol) was added and samples were loaded onto native gel52. First, gels were 
analyzed by in gel protease activity using LLVY-AMC as substrate. Next, samples were 
transferred to pvdf membrane for immunoblotting as described previously38.  
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 Expression and purification of Pba1 and Pba2 complex 
The ORF of PBA1 was amplified from yeast gDNA by PCR using primers pRL145 (5’-
CTG TTG GAT CCA TGC TTT TTA AAC AAT GGA ATG ACT TAC CAG-3’) and pRL146 
(5’-CGG GAA TTC TCA TAT ATA TAG GCC TGA TTG TG-3’). The PCR product was 
cloned into pNU247, a pGEX-6PK-1 derived plasmid, using the enzymes BamHI and EcoRI. 
The ORF of PBA2 was amplified from yeast gDNA by PCR using primers pRL147 (5’-GGC 
AGA TCT TGA AAA CCT GTA TTT CCA GGG ACA GGA TCC GAT GAG CTG CCT GGT 
GTT G-3’) and pRL148 (5’-CTC GAG CTC TCA ATT GTA TAA ATC TAC-3’). The PCR 
product was cloned into pRSF Duet-1 (EMD Millipore) using BglII and BamHI sites. The 
resulting plasmids were introduced together into Rosetta DE3 cells (stratagene) to enable co-
purification of GST-tagged Pba1 and His-tagged Pba2. Transformed cells were inoculated in LB 
supplemented with kanamycin, ampicillin and chloramphenicol and incubated at 37 ºC with 
shaking at 200 rpm. At an OD600 of 0.6, IPTG was added to 0.1 mM final concentration and the 
culture was incubated overnight at 37 ºC with shaking. Cells were harvested by centrifugation 
(6,000 g, 10 min., 4 ºC), washed in sterile H2O and resuspended in lysis buffer (20 mM Tris-HCl 
[pH 8.0], 100 mM NaCl and 0.1% Triton X-100) supplemented with protease inhibitor cocktail 
tablet (Roche). Lysis was performed at 900 psi using a French press system. Lysate was cleared 
by centrifugation (10,000 g, 30 min. at 4 ºC). To the clear cell lysate glutathione agarose resin 
(GoldBio) (100 µl per 100 ml culture) was added and samples were incubated at 4 ºC for 1 hour. 
The resin was washed four times with total 50 bed volumes of PBS buffer containing 0.1% triton 
X-100 and 0.02% Na-azide. To elute the Pba1-Pba2 dimer, resin was washed and resuspended in 
GST precision cleavage buffer (50 mM Tris-HCl [pH 6.8], 150 mM NaCl, 1 mM DTT, and 
0.01% Triton X-100) and incubated overnight in the presence of GST-precision protease. Eluted 
material was further purified using an AKTA purifier with a HiLoad Superdex 200 column 
equilibrated with reconstitution buffer (50 mM Tris-HCl [pH 7.5], 5 mM MgCl2, 50 mM NaCl, 1 
mM ATP, and 1 mM DTT). Fractions containing Pba1-His-Pba2 protein were collected and 
concentrated using 10 KDa concentrator (PALL Life Sciences). 
 Salt dependent binding  
To test for salt dependent binding as described in Figure 2.2, indicated strains were 
processed using our standard proteasome purification protocol, up until the IgG beads washing 
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step. Here, 20 bed volumes of a different wash buffer were used (50 mM Tris‐HCl [pH 7.5], 5 
mM MgCl2, 1 mM EDTA, and 1 mM ATP, 0.1% triton X-100). Next, washed IgG beads were 
distributed equally amongst five eppendorf tubes. Beads were resuspended in 5 bed volumes of 
buffer (50 mM Tris‐HCl [pH 7.5], 5 mM MgCl2, 1 mM EDTA, and 1 mM ATP, 0.1% triton X-
100) containing different concentrations of NaCl (0 mM, 100 mM, 250 mM, 500 mM, and 1000 
mM NaCl) and incubated for 3 minutes at room temperature under rotation. Beads were pelleted 
by centrifugation (500 g, 1 minutes at 4 ºC). This washing step was performed two additional 
times. Next, beads were washed twice with 5 bed volumes of low salt buffer (50 mM Tris‐HCl 
[pH7.5], 5 mM MgCl2, 1 mM DTT, 1 mM ATP, and 0.1% triton X-100). Finally, samples were 
resuspended in 2X SDS-PAGE sample buffer and loaded on 12% SDS-PAGE. 
 Binding affinity measurements 
Binding kinetics of the His-tagged Pba1-Pba2 to purified mature CP were measured using 
bio-layer interferometry on a BLItz instrument (ForteBio). The Pba1-Pba2 complex was 
immobilized on a Ni-NTA biosensor using a 4.5 μM solution. Different concentrations of CP 
(from 0.0 μM to 1.8 μM) in reconstitution buffer (50mM Tris [pH 7.5], 5mM MgCl2, 50mM 
NaCl, 1mM ATP, 10% Glycerol) were used as analyte. Advanced kinetic experiment setup was 
used and kinetic parameters (kon and koff) and affinity (KD) were calculated from a global fit (1:1) 
of the BLItz instrument data using the BLItz software. 
 Cyclohexamide chase 
Specific yeast strains were grown overnight in 5 ml of YPD or minimal selection media. 
The next day, cells were diluted to OD600 0.3 in fresh medium and allowed to grow up to 
logarithmic growth (OD600 1.0). Cells were then treated with cyclohexamide (100µg ml
-1) for the 
indicated number of minutes and cells equivalent to 1 ml of OD600 2.0 of cells were collected at 
each time point. Equal amounts of protein extract from each time point were then loaded on 11% 
SDS-PAGE and a western blot was performed.  
 2D gel analysis 
Ump1-containing immature CP complexes were purified from sJR792 and sJR793 using 
the proteasome purification protocol described above. 25 µg of each purified complex was 
vacuum dried and rehydrated in 140 µl of 2D rehydration buffer (8 M Urea, 2% CHAPS, 20 mM 
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DTT, 0.002% Bromophenol Blue, 0.5% ZOOM® carrier ampholytes pH 3-10 (Life 
technology)). Isoelectric focusing was done using ZOOM® IPG Strips - pH 3-10NL (non-linear) 
according to the manufacturer’s protocol. Next, IEF strips were incubated in 1X SDS PAGE 
sample buffer for 10 minutes. Strips were inserted into 12% percent SDS PAGE to run for the 
2nd dimension. After electrophoresis, gels were either stained with coomassie brilliant blue or 
used to transfer samples to pvdf for subsequent analysis by immunoblotting. 
 Mass spectrometry 
MS-grade solvents were purchased from Burdick & Jackson or Baker, sequencing grade 
trypsin from Promega and other solutions were the highest grade available from Sigma-Aldrich. 
For digestions, samples were denatured by SDS-PAGE (gel bands or spots), reduced with TCEP, 
alkylated with IAA, and digested overnight with 4 µg ml-1 trypsin, using Tris-HCl (pH 8.5) to 
buffer all solutions. For LC-MS/MS analyses, samples were analyzed on a hybrid LTQ-Orbitrap 
mass spectrometer (Thermo Fisher Scientific) coupled to a New Objectives PV-550 
nanoelectrospray ion source and an Eksigent NanoULC chromatography system.  Peptides were 
analyzed by trapping on a 5 cm pre-column using a vented column configuration, followed by 
analytical separation on a New Objective 75 µm ID fused silica column with an integral fused 
silica emitter, packed in house with 40 cm of 3-µm Magic C18 AQ beads.  Peptides were eluted 
using a 5-40% ACN/0.1% formic acid gradient performed over 100-200 min at a flow rate of 
250 nL min-1.   
  During elution, samples were analyzed using Top Six methodology, consisting of one 
full-range FT-MS scan (nominal resolution of 60,000 FWHM, 300 to 2000 m/z) and six data-
dependent MS/MS scans performed in the linear ion trap.  MS/MS settings used a trigger 
threshold of 8,000 counts, monoisotopic precursor selection (MIPS), and rejection of parent ions 
that had unassigned charge states, were previously identified as contaminants on blank gradient 
runs, or that had been previously selected for MS/MS (dynamic exclusion at 150% of the 
observed chromatographic peak width).   
  MS Data analysis  
Centroided ion masses were extracted using the extract_msn.exe utility from Bioworks 
3.3.1 and were used for database searching with Mascot v2.2.04 (Matrix Science). The search 
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parameters used were: 6.0 PPM parent ion mass tolerance, 0.6 Da fragment ion tolerance, allow 
up to 1 missed cleavage; variable modifications, carbamidomethyl (C), oxidation (M), 
propionamide (C), and pyro-glu (N-term Q). Database searching was conducted using the 
Saccharomyces cerevisiae plus filter, resulting 134809 entries. Peptide and protein 
identifications were validated using Scaffold v2.2.00 (Proteome Software) and the 
PeptideProphet algorithm53. Searches were performed using thresholds of 1% peptide false 
discoveries and 1% protein false discoveries with at least two peptides identified. Proteins that 
contained similar peptides and could not be differentiated based on MS/MS analysis alone were 
grouped to satisfy the principles of parsimony.  
 MALDI-TOF Analyses 
Protein spots and gel blanks from 2-D gels were excised and digested with trypsin (8 µg 
ml-1).  For MALDI-TOF analyses, peptide extracts were mixed with alpha-cyano-4-hydroxy-
cinnamic acid and analyzed on a Voyager DE-PRO instrument operated in reflectron mode.  
Individual TOF spectra were routinely externally calibrated with a known peptide mix (100 ppm 
accuracy).  Supplemental strategies included desalting and concentration of peptide extracts on 
miniature C-18 affinity columns (OMIX tips from Agilent), and internal recalibration of 
MALDI-TOF spectra using trypsin autolysis products (20 ppm accuracy).  MALDI-TOF ion 
peaks were extracted using Data Explorer 4.0. Spectra were deisotoped at a peak detection 
threshold of 5% BP intensity, and a peak list from the m/z range 500 to 3000 was built using the 
five most intense peaks from each 100-m/z interval.  Alternatively, weaker spectra were 
analyzed using manually optimized peak detection windows that visually tracked the baseline 
noise threshold.  Peptide mass fingerprint searches were conducted using MASCOT (v2.2).  
Protein identifications were accepted if their MASCOT probability based MOWSE scores 
(PBM) were statistically significant, and if the PBM of the top-ranked candidate was markedly 
superior to that of the next-ranked candidate.  Experimental peptide masses were assessed for 
systematic divergence from hypothetical calculated peptide masses, wherein random mass 
deviations were used to reject candidate identifications.  
 Numerical simulation 
Our model of proteasome assembly was represented as a system of Ordinary Differential 
Equations (ODEs).  We numerically integrated these ODEs using the CVODE library in the 
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SUNDIALS package54. A description of the model itself, along with the full set ODEs, can be 
found in the Supplementary Note 1 and Supplementary Note 2 respectively of the online 
supplementary file of journal article. The concentrations of the different proteins in this model 
were estimated from experimental measurements in yeast55, and the interaction parameters 
(association rates, dissociation rates, affinities, etc.) were taken from bio-layer interferometry 
measurements (Appendix Figure A.2A).   
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 Results 
 The Pba1 and Pba2 complex prevents RP binding 
As mentioned above, Pba1-Pba2 and Blm10 likely compete with each other for binding 
to the CP α-ring.  Consistent with this idea, upon purification of proteasomes from pba1Δ, 
pba2Δ or pba1Δpba2Δ yeast strains we observed increased levels of Blm10 (Fig. 2.1A, 2.1B, 
and Appendix Figure A.1).  However, in vivo Pba1-Pba2 is normally only found on the immature 
CP, and it has been postulated that one function of Pba1-Pba2 could be to prevent RP from 
binding to immature CP8,9,35,36. To test this hypothesis, we first affinity-purified immature CP 
using TAP-tagged Ump1 (Fig. 2.1C and 2.1D). Mass spectrometry analyses confirmed that these 
purifications contained all seven α subunits in addition to β1 to β5, Pba1, Pba2 and Ump1 
(Appendix Table A.1).  β6 (Pre7) and β7 (Pre4) were undetectable, as has been observed 
before37. The presence of Pba1-Pba2 was also confirmed by immunoblotting (Fig. 2.1C and 
Appendix Figure A.1). Propeptides for β1, β2, and β5 were detected by immunoblotting or mass 
spectrometry (Fig. 2.1C and Appendix Table A.1). Taken together, these data indicate we 
purified a form of CP that has not matured yet.  
RP was not detected above background levels in purifications of immature CP when 
assessed using several RP specific antibodies (Fig. 2.1C). To understand how the presence of 
Pba1-Pba2 might impact interactions of RP with the immature CP, we deleted PBA1. The 
deletion of PBA1 resulted in the absence of both Pba1 and Pba2 from immature CP, and the 
appearance of the RP (Fig. 2.1C). Thus, upon deletion of Pba1, the surface of the α-ring becomes 
available for interaction with RP. Particularly striking was the presence of Ecm29 in this deletion 
background; Ecm29 is a proteasome-associated protein that only associates with RP-CP species 
and not free RP or free CP38,39. It has been found recruited to mutant proteasome forms29,40, 
potentially indicating specific recruitment on these samples where RP associates prematurely 
with CP. 
Previously, it has been shown that Blm10 associates with both mature CP17,26,27,38 and 
immature CP15,16,26. We consistently observed higher levels of Blm10 on immature CP purified 
from a pba1Δ strain compared to wildtype (Fig. 2.1C and Appendix Figure A.1). The deletion of 
BLM10 together with PBA1 caused a modest further increase of RP binding to immature CP, 
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consistent with the fact that the RP and Blm10 compete for CP binding. Interestingly, a deletion 
of BLM10 in strains that contain functional Pba1-Pba2 did not cause the RP to associate with 
immature CP (Appendix Figure A.1), suggesting that it is mainly the Pba1-Pba2 dimer that 
blocks association of RP with immature CP.  
Figure 2.1 Pba1-Pba2 prevents RP association with immature CP. 
 
 
 
(A) Proteasomes were purified from indicated strains, resolved by SDS-PAGE, and stained with 
Coomassie Brilliant Blue (CBB). (B) Native gel analysis of samples from (A) stained in gel with 
the proteasome substrate suc-LLVY-AMC (left) or stained with CBB. (C) 26S proteasome or 
immature CP were affinity-purified using ProA-tagged β4 or TAP-tagged Ump1 respectively. 
Purified complexes were resolved on SDS-PAGE and stained with CBB (top) or immunoblotted 
for Pba1-Pba2, indicated proteasome subunits (CP indicates core and RP indicates regulatory 
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particle subunits), and Ecm29. The asterisk marks a non-specific band. (D) 26S proteasome and 
CP were purified using standard protocols. Immature CP was purified and washed with buffers 
containing the indicated NaCl concentrations. Samples were resolved on a native gel and stained 
with either suc-LLVY-AMC (top) or with CBB (bottom). 
Analysis of immature CP on native gel shows a distinct band that migrates faster than CP 
and lacks hydrolytic activity (Fig. 2.1D). The deletion of PBA1 resulted in a smear instead of a 
well-resolved species (Fig. 2.1D lower panel). This smearing is likely caused by different factors 
associated with the immature CP in the absence of Pba1-Pba2, since including a washing step 
with high salt resulted in a more distinct band on native gel (Fig. 2.1D lower panel). The band 
does not migrate similar to wildtype immature CP, which might be caused by the absence of 
Pba1-Pba2 or a different composition of the immature CP (Fig. 2.1C and below).  Our results 
thus indicate that the Pba1-Pba2 dimer shields the immature CP from other factors that can 
interact with the α-ring surface. 
 RP readily displaces Pba1 and Pba2 from mature CP 
Crystal structures of Blm10 or Pba1-Pba2 bound to the CP and cryoEM structures of RP-
CP complexes show that they bind with the CP exclusively through the α ring8,12-14. Since both 
Ump1-bound immature CP (Appendix Table A.1) and mature CP have a complete α1-7 ring, it is 
unclear what drives the difference in binding behavior observed between mature CP and 
immature CP.  An attractive mechanism that has been proposed posits that Pba1-Pba2 binds to 
immature CP, but upon maturation, Pba1-Pba2 is degraded, which enables the formation of RP-
CP complexes. This model is supported by the observation that, upon overexpression of a flag-
tagged version of the human orthologs PSMG1 (PAC1) or PSMG2 (PAC2), the flag-tagged 
protein is unstable in Hela cells9. On the other hand, for the yeast orthologs no detectable 
degradation of Pba1-Pba2 by the mature CP has been observed in vitro7,8.   
To test the stability of Pba1-Pba2 in vivo, we conducted chase experiments using an 
antibody that recognizes endogenous Pba1-Pba2 (Fig. 2.2A). These data suggested that the Pba1-
Pba2 dimer is stable. To address the possibility that one of the two subunits is unstable, we next 
determined steady state levels of Pba1 and Pba2 in the pba2Δ and pba1Δ strains respectively. 
Here, a subtle difference in migration between the two proteins can be observed, indicating the 
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antibody recognizes both endogenous Pba1 and endogenous Pba2 (Fig. 2.2B). The strongly 
reduced signal upon deletion of PBA1 or PBA2 might indicate that subunits incapable of forming 
dimers are subject to degradation in a process unrelated to CP maturation. This finding could 
potentially explain perceived differences between the yeast and mammalian systems9. Finally, 
we also reintroduced a His-Myc-tagged version of Pba2 in a pba2Δ background using a CEN 
plasmid and the endogenous promoter to prevent overexpression. Chase experiments with the 
later strain also showed both subunits are stable (Fig. 2.2C). In sum, our findings indicate that 
Pba1-Pba2 is not degraded as part of the CP maturation process in yeast. 
Figure 2.2 Pba1 and Pba2 are stable. 
 
 
(A) Cyclohexamide chase of wildtype using antibodies that recognize endogenous Pba1-Pba2. 
100 µg ml-1 of cyclohexamide was added to logarithmically growing samples at t=0. Samples 
were collected at indicated times and lysed in SDS sample buffer. Immunoblots show levels of 
Pba1-Pba2 with Pgk1 as a loading control. Pba1-Pba2 has a long half-life inconsistent with the 
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previously proposed model that Pba1-Pba2 is degraded during the assembly process. (B) Steady 
state levels of Pba1-Pba2 in total lysate. (C) Cyclohexamide chase as in (A) but from a strain 
that expresses His-Myc-tagged Pba1 from a CEN plasmid under its own promoter.  
 
Since CP does not degrade Pba1-Pba2, RP must be able to displace it directly or with the 
help of other factors. Previous work using surface plasmon resonance had shown that the 
interaction between mature CP and Pba1-Pba2 is salt-labile8. We also observe that this 
interaction can be disrupted with low salt concentrations when we reconstituted E. coli purified 
Pba1-Pba2 onto resin-bound CP purified from yeast (Fig. 2.3A). Using bio-layer interferometry, 
we measured a KD of ~ 1 µM for Pba1-Pba2 with mature CP in 50 mM NaCl (Appendix Figure 
A.2), which is similar to the 3 µM reported by Stadtmueller et al. under physiological salt 
concentrations8. Considering the reported nanomolar range affinities between the RP subunit 
containing complexes and CP21,30, these findings suggest that the RP will likely displace Pba1-
Pba2 from the mature CP.  
To further test this we developed an in vitro reconstitution assay. First, we combined 
mature CP with increasing ratios of Pba1-Pba2 to determine the stoichiometry of binding on 
native gel. Pba1-Pba2 binds to the CP, but does not cause a mobility shift (Appendix Figure 
A.2). Since a fivefold excess of Pba1-Pba2 showed maximum CP binding, we challenged 
reconstitutions with that ratio of Pba1-Pba2 to CP with increasing amounts of RP (Fig. 2.3B). 
We found that the RP associates with the CP starting at low concentrations where Pba1-Pba2 is 
in 20 fold excess over RP. This indicates that the RP can readily replace Pba1-Pba2 bound to 
mature CP. These analyses are complicated by a small amount of active RP2-CP that co-purifies 
with our RP preparations (38 and Fig. 2.3B lane 2). However, looking at the singly-capped RP-
CP or visualizing exclusively the reconstituted CP by utilizing YFP-tagged CP (Fig. 2.3B lowest 
panel), we know the RP is reconstituted onto Pba1-Pba2-CP complexes. These data suggest that 
Pba1-Pba2 bound to mature CP cannot prevent RP association. Hence, there is no need for Pba1-
Pba2 degradation to produce RP-CP complexes.  
Figure 2.3 CP undergoes affinity switch upon maturation.  
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 (A) Affinity-resin bound purified CP was reconstituted with heterologously expressed His-
tagged Pba1-Pba2 dimer. Samples were washed with buffer containing the indicated NaCl 
concentrations. Next, samples were resolved on SDS-PAGE and stained with CBB or 
immunoblotted for the indicated proteins. (B) YFP-tagged CP was first reconstituted with 5 fold 
molar excess of Pba1-Pba2 and challenged with different amounts of purified RP (molar excess 
over CP indicated). Samples were resolved on a native gel to determine complex composition in 
samples: Top panel, proteolytic active complexes were visualized using in gel suc-LLVY-AMC 
hydrolytic activity assay. Middle panel, native gel was immunoblotted for the RP subunit Rpn1. 
Lower panel, native gel was analyzed for YFP signal. (C-F) Immature CP or 26S proteasome 
from wildtype or indicated strains were purified, split into different samples and washed with 
buffer containing the indicated NaCl concentrations. Samples were resolved on SDS-PAGE and 
stained with CBB or immunoblotted for indicated proteins. The asterisk indicates an IgG resin-
derived band. 
 
 A switch in affinity upon CP maturation 
We hypothesized that a specific mechanism must exist that ensures Pba1-Pba2 cannot be 
replaced by RP when bound to immature CP. This could involve regulatory proteins, like the RP 
chaperones that associate with RP complexes. However, those chaperones cannot fully prevent 
RP-immature CP association as we observed RP binding in pba1Δ cells (Fig. 2.1C). As an 
alternative mechanism, we envisioned a conformational change in the α ring upon maturation 
that changes the binding surface between the CP and associated proteins. In general, the CP has 
more structural plasticity then has been appreciated41.  More specifically, during the final steps of 
CP maturation, β7 is incorporated, immature CP dimerizes, autoproteolytic cleavage activates the 
three active sites (β1, β2 and β5), and Ump1 is degraded2. The β7 subunit is in direct contact 
with the α-subunits that bind to Pba1-Pba2, α6 and α7 8, providing a direct opportunity to induce 
a conformational change in the α ring. Alternatively, autoproteolytic activation might provide a 
trigger that induces a conformational change in CP, as modification of active sites has been 
shown to change properties of the α-ring38,42.  
To test for differences in binding behavior between mature and immature CP, we 
characterized the salt dependence of several different interactions. First, we used TAP-tagged 
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Ump1 to purify immature CP associated with endogenous Pba1-Pba2. Here, even washes with 
buffers containing 1M NaCl washed off very little of the Pba1-Pba2 complex from immature CP 
(Fig. 2.3C). This is in sharp contrast to the Pba1-Pba2 association with mature CP, which is 
highly salt labile (Fig. 2.3A and 8). Next, to test if the RP also shows a change in binding 
behavior, we purified immature CP from the pba1Δ blm10Δ strain and exposed it to washes with 
different salt concentrations.  In these samples, the RP consistently washes off in buffers 
containing 100 mM NaCl (Fig. 2.3D), while 250 to 500 mM NaCl is required to disrupt the 
binding between RP and mature CP (Fig. 2.3E and 39).  These data suggest that the immature CP 
has a high affinity for Pba1-Pba2 and a low affinity for the RP. Upon maturation, the affinities 
are reversed and the RP has a much higher affinity for the mature CP than Pba1-Pba2. For RP 
binding to the immature CP we cannot exclude that the reduced binding is due to differences in 
immature CP composition upon PBA1 deletion (see below). However, in reconstitution assays 
we were unable to expel Pba1-Pba2 from normal immature CP, even though the base 
subcomplex of the RP efficiently reconstituted on mature CP (Appendix Figure A.2C and A.2D) 
and can expel Pba1-Pba2 from mature CP (Fig. 2.3B). Interestingly, the binding of Blm10 to 
both mature and immature CP shows a disruption of the interaction at similar salt concentrations, 
suggesting that Blm10 is not sensitive to the affinity switch (compare Fig. 2.3C and 2.3E). This 
is consistent with the fact that Blm10 has been observed on mature as well as immature CP under 
physiological conditions17,26. In all, these data reveal an affinity switch during CP maturation that 
at least in part can explain the exclusive binding of Pba1-Pba2 to immature CP and RP to mature 
CP.   
 The Pba2 tail contributes to the affinity switch 
Pba1 and Pba2 both contain an HbYX-motif that is required for functionality7,8, and a 
crystal structure of Pba1-Pba2 bound to the CP shows that both C-termini dock in a specific α-
pocket8. Interestingly, in the interaction with the mature CP, the tail of Pba2 contributes only 
minimally to binding, since its deletion reduces the affinity with only 2-3 fold8. In comparison, 
deleting the tail of Pba1, reduced the affinity > 100 fold.  The differential contribution to the 
affinity can be rationalized through analysis of the structure itself. Pba2 binds in an unusual 
manner to the CP, lacking several hydrogen bonds commonly observed for HbYX-motif binding 
in the α pockets (e.g. for the HbYX of Pba1 or Blm10). For example, the hydroxyl group of the 
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tyrosine residue in the Pba2 HbYX-motif is far (4.2 Å) removed from the closest potential 
hydrogen bond partner8,12. Despite the apparent minor role in binding to the CP, the HbYX-motif 
of Pba2 is physiologically relevant, since mutant strains with a truncated tail show phenotypes 
similar to mutants lacking the Pba1 HbYX-motif7,8. Only after deletion of both HbYX-motifs, 
however, do strains show phenotypes that mimic pba1Δ strains7,8. Hence, the HbYX-motif of 
Pba2 has an unidentified but important physiological function. We hypothesized that the HbYX-
motif of Pba2 is more important for binding with the immature CP as compared to the mature 
CP, thereby contributing to the observed affinity switch. Such a difference might arise from 
small changes in the conformation of the α6-α7 pocket, or from the fact that changes in Pba1-α5-
α6 interactions could limit the ability of Pba2 to interact fully with its pocket in the mature CP.   
The model described above predicts that both the Pba2 and Pba1 HbYX-motif would 
have a role in binding to the immature CP. To test this, we deleted the HbYX-motif from Pba1 
(pba1-ΔCT3), Pba2 (pba2-ΔCT3), or both together (pba1-ΔCT3 pba2-ΔCT3) in an Ump1-Tap 
tagged background. Next, we tested the salt lability of Pba1-Pba2 binding to immature CP. To 
our surprise, Pba1-Pba2 remained bound to immature CP in both the pba1-ΔCT3 and pba2-
ΔCT3 background even after washes with 1 M NaCl (Fig. 2.3F).  The binding of Pba1-Pba2 to 
the immature CP is thus very different compared to the mature CP, as the latter showed a highly 
salt dependent interaction that depends largely on the Pba1 tail (Fig. 2.3A and 8). Only after 
deletion of both the Pba1 and Pba2 HbYX-motif (pba1-ΔCT3 pba2-ΔCT3) did we observe loss 
of binding of the Pba1-Pba2 complex to immature CP with high salt washes (Fig. 2.3F). Thus, in 
contrast to binding to mature CP, both the Pba1 and Pba2 HbYX-motif contribute substantially 
to the affinity of Pba1-Pba2 for immature CP. This suggests that a major contributor to the 
molecular mechanism of the affinity switch derives from differences in how the Pba2 HbYX-
motif docks into the α6-α7 pocket. 
 Pba1 and Pba2 contribute to α5 and α6 incorporation 
On purification of immature CP from a pba1Δ strain we noticed a reduced level of a 
specific proteasome core particle subunit after SDS-PAGE analysis (compare Fig. 2.3C and 
2.3D). Based on the running behavior, previous assignments by other labs26,43 and our own mass 
spectrometry analysis (Fig. 2.4A and 2.4B) we determined this was the subunit α6. This suggests 
that there is a reduced level of α6 present in immature proteasomes in the absence of Pba1. 
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Additional mass spectrometry analysis suggested that besides α6 there might also be reduced 
levels of α5. To test this, we ran 2D gels of mature CP from wildtype and immature CP from  
Figure 2.4 . Pba1-Pba2 are required for efficient incorporation of α5 and α6 
 
 (A) Immature CP from wildtype strain was purified and resolved on SDS-PAGE. Two bands that 
were consistently absent or reduced in a pba1Δ background (See Fig. 2.1C, 2.3C, and 2.3D) 
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were excised and submitted to mass spectrometry analysis for identification (see Table 1). Band 1 
was identified as Pba1 and Pba2, while α6 was the major component of Band 2, consistent with 
previous assignments15,26,43. (B) Unique peptides from the mass spectrometry analyses in (a) that 
cover regions of the pro-peptides of β1, β2, and β5 are underlined with the pro-peptide sequence 
in bold. (C) Purified mature or immature CP from indicated strains were resolved by two-
dimensional gel electrophoresis using a non-linear ZOOM® IPG strip (pH 3–10) followed by 
SDS-PAGE. Gels were stained with CBB. Proteins spots were assigned based on immunoblotting 
(Appendix Figure A.3A), mass spectrometry analyses (underlined and Appendix Figure A.3B), 
and previous assignments26,43.  
 
Table 2.2 Mass spectrometry analyses of band 1 and band 2 in Figure 2.4 
Band 
Protein 
Name 
Standard 
Name 
Systematic 
Gene Name 
# unique 
peptides 
# total 
Spectra 
% coverage 
1 
Pba1 Pba1 YLR199C 9 25 42 
Pba2 Add66 YKL206C 10 23 35 
α5 Pup2 YGR253C 7 10 28 
β5 Pre2 YPR103W 6 8 21 
α7 Pre10 YOR362C 4 7 18 
α4 Pre6 YOL038W 5 6 23 
α1 Scl1 YGL011C 2 2 8 
2 
α6 Pre5 YMR314W 16 32 75 
Ump1 Ump1 YBR173C 7 20 47 
β1 Pre3 YJL001W 9 15 39 
β5 Pre2 YPR103W 2 2 9 
β2 Pup1 YOR157C 2 2 8 
 
wildtype and pba1Δ strains (Fig. 2.4C and Appendix Figure A.3). These gels confirmed the 
substantial reduction in levels of α5 and α6 from immature CP purified from pba1Δ strains.  
Pba1 thus likely has a role in efficient incorporation of α5 and α6, similar to Pba3-Pba4, which 
has a role in controlling α3 (Pre9) and α4 (Pre6) incorporation.  However, α5 and α6 are essential 
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subunits of the proteasome, making a potential role for Pba1-Pba2 in formation of alternative 
proteasomes, as was proposed for Pba3-Pba43, unlikely. Considering the thermodynamic 
stability of rings once they have formed44-46, the reduced level of these two subunits most likely 
indicates a slow incorporation of these subunits into the α ring in a pba1Δ strain. However, and 
alternative or additional role of Pba1-Pba2 might be the stabilization of α5 and α6 once they have 
been incorporated into the α ring, in particular as α5 and α6 appear to be absent in the high salt 
wash of the pba1-ΔCT3 pba2-ΔCT3 strain (Fig. 2.3F). 
 Preventing premature RP binding improves assembly efficiency 
Our data provide experimental evidence and mechanistic insight into a role of Pba1-Pba2 
in preventing binding of RP to immature CP.  To better understand the importance of the 
observed affinity switch, we developed a mathematical model in which we manipulated the 
affinity of Pba1-Pba2 for the CP α ring.  
In our model of proteasome assembly, the α-ring is nucleated by the formation of an α5-
α6 dimer and we kept the roles of the Pba3-Pba4 chaperone1,47,48 implicit. After α-dimers form, 
other α subunits can bind on either end of the complex, eventually leading to the formation of the 
α ring. We ignored subsequent steps in CP maturation (addition of the β subunits, half 
proteasome dimerization, etc.) in order to reduce the complexity of the model. To test the effect 
of the proposed affinity switch, we used various affinities for Pba1-Pba2 dimer bound to 
intermediates as well as the full α-ring. We only included fully-formed RPs in this model, 
assuming the RP chaperones would prevent association between immature RPs and CP 
subunits28-31,33,34. Finally, since the Rpt ring of the RP makes many contacts with the α subunits 
of the CP13,49, RP binding to α-ring structures was considered to be stable when the α- 
intermediate in question contained more than one subunit44-46.  
We used this model to analyze how proteasome assembly efficiency (defined as the 
formation of fully active 26S RP-CP complexes) depends on the concentration of Pba1-Pba2 for 
three different scenarios. In the first, we implemented the affinity switch that was implied by our 
data (Fig. 2.5A and 2.5B, black lines). In the affinity switch model, the KD of Pba1-Pba2 for the 
mature CP was taken to be 1 µM (Appendix Figure A.2A), and the KD of Pba1-Pba2 for 
immature CP was taken to be 3 orders of magnitude stronger (1 nM) to represent the lack of 
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dissociation of the chaperones from immature CP even in high salt (Fig. 2.3C). The other two 
scenarios lacked an affinity switch and the affinity of Pba1-Pba2 for mature and immature CP 
was either low (1 µM, “low affinity”, Fig. 2.5A and 2.5B, red lines) or high (1 nM, “high 
affinity”, Fig. 2.5A and 2.5B, green lines). 
Figure 2.5 Pba1-Pba2 prevents assembly deadlock. 
 
 
(A) Mathematical models were designed to investigate the function of Pba1-Pba2 (see text for 
details). The graph explores three scenarios. In the first (black line), we incorporated an affinity 
switch in our model. The Y-axis shows fraction of assembled proteasomes, which reaches 1 
within the likely physiological range of concentrations of Pba1-Pba2 in the presence of an 
affinity switch (gray area).   The second scenario (green line) assumed a high affinity rather than 
an affinity switch, while the third considered a low affinity (red line).  (B) This graph displays 
the fraction of complexes where the RP is associated with the CP prior to CP maturation, 
yielding unproductive, deadlocked complexes. (C) Proposed conceptual model for the role of 
Pba1-Pba2 in CP maturation (see text for details).  
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As can be seen in Figure 2.5A, the behavior of these three scenarios is quite different. 
The presence of an affinity switch results in very high assembly yield compared to the absence 
(i.e. very low concentrations) of Pba1-Pba2; going from 75% to almost 100%. The improved 
assembly results from a decrease in RP binding to immature CP intermediates (Fig. 2.5B). When 
the concentration of Pba1-Pba2 reaches unphysiologically high levels (~100 µM), it overcomes 
the affinity switch and begins to interfere with 26S assembly by blocking RP association with 
mature CP (Fig. 2.5A). The 75% yield in the absence of Pba1 or Pba2 fits well with in vivo data, 
where the deletion of Pba1 or Pba2 does not cause a severe phenotype25,26, but likely causes a 
reduction in assembly yield substantial enough to explain synergistic phenotypes with other 
proteasome mutants25,26.  
If we remove the affinity switch, however, the robust increase in assembly yields due to 
the presence of Pba1-Pba2 is no longer observed in the model.  When affinities are uniformly 
low (Fig. 2.5A, red line), Pba1-Pba2 simply does not bind either immature or mature CP well 
enough at physiological concentrations to have an impact on assembly yields. When affinities are 
uniformly high, on the other hand, Pba1-Pba2 block RP binding to both the mature and immature 
CP, resulting in lower yields (Fig. 2.5B, green line). 
While the results in Figure 2.5 suppose a particular concentration of both RP and CP 
subunits in the cell, independent variations in these concentrations do not influence the overall 
trends observed in the model (Appendix Figure A.4A).  Similarly, changes to the size of the 
affinity switch also do not influence the general behavior of the model (Appendix Figure A.4B). 
Our model thus provides a robust explanation for the functional role of the Pba1-Pba2 affinity 
switch: by blocking premature RP-CP association, these chaperones prevent the stabilization of 
intermediates that would lead to CP assembly deadlock44. The switch from a high-affinity to 
low-affinity binding conformation upon CP maturation ensures that the chaperone “gets off” the 
complex at the right time, allowing the RP to bind once the CP is fully formed. 
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 Discussion 
Figure 2.5C summarizes our current conceptual model of the role of Pba1-Pba2. CP 
assembly starts with the formation of the α1-7 ring. In the early steps of assembly, both the Pba1-
Pba2 and the Pba3-Pba4 dimers have a role in efficient ring formation. Pba3-Pba4 has a role in 
ring nucleation and ensures incorporation of α33. The presence of Pba1-Pba2 ensures the 
efficient incorporation or stabilization of α5 and α6. Next, the β-subunits assemble onto the α-
ring; at this step in the process, Pba3-Pba4 must dissociate from the complex to avoid steric 
clashes with the β4 subunit4. However, Pba1-Pba2 remains bound until late in the assembly 
process, shielding the external surface of the α-ring from RP and Blm10 and also preventing α-
ring dimerization9.   
After assembly of the β-ring several steps must occur, including dimerization of 
immature half proteasomes and autocatalytic activation1,48. Our results show that maturation of 
the CP causes a change in the binding of Pba1-Pba2 to the CP. While the structural basis of the 
affinity switch has yet to be determined, our data suggest that conformational changes in the CP 
that accompany maturation impact the capacity of the HbYX-motif on Pba2 to interact with the 
α6-α7 pocket. The affinity switch we have identified allows the chaperone to specifically protect 
the immature CP from interactions with regulatory factors, thereby preventing the formation of 
unproductive complexes that decrease the assembly yield of functional proteasomes. It is likely 
that other assembly chaperones (particularly those that bind to immature RPs, e.g. Nas6) utilize a 
similar mechanism, preventing association with larger assemblies prior to completion of 
subcomplex assembly. Small structural changes that accompany maturation likely reduce the 
affinity for these chaperones, allowing for the coordinated exchange of possible binding partners 
during the assembly process. 
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 Abstract 
 
The proteasome degrades many short-lived proteins that are labeled with an ubiquitin 
chain. The identification of phosphorylation on the proteasome suggests that degradation of these 
substrates can also be regulated at the proteasome. In yeast and humans, the unstructured C-
terminal region of α7 contains an acidic patch with serine residues that are phosphorylated. 
Although these were identified more than a decade ago, the molecular implications of α7 
phosphorylation have remained unknown. Here, we showed that the yeast Ecm29, a protein 
involved in proteasome quality control, requires the phosphorylated tail of α7 for its association 
with proteasomes. This is the first example of proteasome phosphorylation dependent binding of 
a proteasome regulatory factor. Ecm29 is known to inhibit proteasomes and is often found 
enriched on mutant proteasomes. We showed that the ability of Ecm29 to bind to mutant 
proteasomes requires the α7 tail binding site, besides a previously characterized Rpt5 binding 
site. The need for these two binding sites, which are on different proteasome subcomplexes, 
explains the specificity of Ecm29 for proteasome holoenzymes. It was also a key prediction of 
our model that proposes Ecm29 can recognize a misalignment between those two subcomplexes.  
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 Introduction 
The ubiquitin proteasome system (UPS) is present in all eukaryotes and enables cells to 
degrade many proteins in a highly regulated fashion1. Numerous enzymes are required to 
specifically label proteins that are destined for degradation with ubiquitin. Ubiquitin, a short 
polypeptide, is normally covalently attached to lysine residues present in the target protein. The 
ubiquitinated proteins become substrates for the proteasome, a 2.5 MDa protease complex. The 
proteasome holoenzyme consists of 33 unique polypeptides that are assembled into two main 
subcomplexes: the regulatory particle (RP) and the core particle (CP).  The RP recognizes 
ubiquitinated substrates either through direct interaction with proteasome subunits that function 
as ubiquitin receptors, like Rpn10 or Rpn13, or through recognition of adaptors that bind 
ubiquitinated substrates and the proteasome, such as Rad23 or Dsk2. The RP removes the 
ubiquitin from substrates and unfolds them. The unfolding occurs at an AAA-ATPase ring 
formed by the six homologous proteasome subunits Rpt1 to Rpt6. The Rpt ring abuts the CP and 
is responsible for threading substrates into the CP where the proteolytic active sites are located.  
The CP is formed by four hetero-heptameric rings that are stacked upon one another, resulting in 
a hollow, cylinder-like structure. CP subunits are of two types, α and β
rings to form an α1-7β1-7β1-7α1-7 structure. β1, β2, and β5 are the catalytic subunits that provide the 
protease activity required for protein degradation.  
The proteasome is an abundant complex in the cell, therefore it is important for the cell to 
assemble all 66 subunits that comprise this RP2-CP complex efficiently and correctly. To achieve 
this, proteasome assembly is tightly orchestrated in the cell with the help of ten dedicated 
assembly chaperones2, 3. Five of these chaperones, Hsm3, Nas2, Nas6, Rpn14, and Adc17, are 
dedicated to RP assembly. The other five chaperones, Pba1, Pba2, Pba3, Pba4, and Ump1, assist 
in CP assembly. Interestingly, these chaperones not only promote the formation of specific 
subcomplexes, but several also prevent the premature association of RP and CP. For example, 
the CP chaperones Pba1-Pba2 prevent the association of RP with immature CP 4, 5. Similarly, the 
RP chaperones are capable of blocking mature CP from interacting with RP 6-9. Thus, it appears 
that the final step in assembly, the association of CP with RP, is tightly controlled.  
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The chaperones, under normal conditions, only bind to proteasome subcomplexes and are 
not found on the holoenzyme or mature CP. Several other proteasome-associated components 
have been identified that have binding sites on either CP or RP 10. However, these have also been 
found associated with 26S proteasomes or mature CP, suggesting they regulate proteasome 
activity or assist in proteasome function. Indeed, several assist in delivery of substrates to the 
proteasome, modify the ubiquitin chains on substrates, or change the hydrolytic activity of the 
core particle10. Ecm29 is a unique proteasome component as it is the only one known to bind to 
the RP (Rpt5) as well as the CP 11, 12. Nevertheless, it is normally only found on singly and 
doubly capped proteasomes, i.e. RP-CP complexes and RP2-CP complexes 
11, 13.  
Ecm29 is a large protein (210 kDa) predicted to contain 29 HEAT repeats. Both CryoEM 
analyses and structure predictions of Ecm29 suggest that Ecm29 forms an elongated and curved 
protein similar to many other proteins with multiple HEAT repeats 11, 14. Several functions have 
been proposed for yeast Ecm29 and the human ortholog KIAA0368. For example, it has been 
suggested to remodel proteasomes under stress conditions15, 16, as well as play a role in localizing 
proteasomes to membrane components17-19. Initially, it was thought to positively regulate 
proteasome function as it stabilizes the RP-CP interaction in the absence of nucleotide 11, 13. 
However, Ecm29 has been shown to inhibit proteasome activity in vivo and in vitro 12, 20.  
The inhibition by Ecm29 involves two mechanisms: first, Ecm29 binding induces closure 
of the substrate entry channel 15, 20. This channel is found on the top and bottom of CP and is 
normally opened by RP. Second, Ecm29 reduces the ATPase activity of proteasomes. This 
ATPase activity is required to unfold substrates so that they can enter the CP 12. Interestingly, 
Ecm29 has been found enriched on a variety of proteasome mutants 15, 20-22. These and other data 
led to the proposed function of Ecm29 as a quality control factor that recognizes aberrant 
proteasomes 12, 20-22. 
It remains poorly understood why Ecm29 is enriched on mutant proteasomes. Ecm29 
could specifically recognize faulty proteasomes 12, it could be an unstable proteasome substrate 
that is stabilized resulting from reduced proteasome activity 21, 22, or it could be upregulated in 
strains with proteasome mutations 15. To better understand how Ecm29 associates with the 
proteasome and regulates proteasome activity, it is crucial to understand where Ecm29 binds to 
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the proteasome complex. Using a crosslinking approach on purified proteasomes, followed by a 
purification of Ecm29 and mass spectrometry analyses to identify proteins, we previously 
identified the RP subunit Rpt5 as an interaction partner of Ecm29  12. However, no CP subunits 
were identified.  
Here, we report the identification of an Ecm29 binding site on the core particle subunit 
α7. Truncation of the C-terminal tail of α7 substantially diminishes the Ecm29 interaction with 
the proteasome in both wild type and in mutant proteasomes. Phenotypic analyses confirm that 
this tail of α7 is important for Ecm29 binding to proteasomes in vivo as well. Interestingly, the 
tail of α7 has a conserved acidic region that contains three serine residues that are known to be 
phosphorylated. Mutation of these sites indicates that Ecm29 depends on α7 phosphorylation for 
its interaction with the CP. Thus, our data reveal an additional level of complexity to the binding 
of Ecm29 to proteasomes and identify a function for the phosphorylation sites in the tail of α7. 
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 Experimental procedures 
 Yeast techniques, plasmids and reagents  
Yeast strains used are summarized in table 1. Genomic manipulation of yeast was done 
using a PCR based approach 56, 57. Upon transformation of yeast, successful integration was 
confirmed by positive PCR for integration and negative PCR for wild type. To make α7-Δ40, 
primer pRL207: 5’- TGC TAC AGG AAG CTA TCG ATT TTG CCC AAA AAG AAA TTA 
ACT GAG GCG CGC CAC TTC T-3’ and pRL66: 5’-TCA ACT CTT TGG TTC TTC TTA 
ACG TAT TAT CAG AAT GTC ATC GAT GAA TTC GAG CTC G -3’ were used. α7-Δ19 
that contains the acidic patch and phosphorylation sites, primers pRL 248: 5’-TGA CAG TGA 
TAA CGT CAT GTC CAG TGA TGA TGA AAAT GCT TGA GGC GCG CCA CTT CT -3’ 
and pRL66, for α7-Δ19 (S/A) that replaces three Serine to Alanine (S258A, S263A and S264A) 
from α7 tail pRL319: 5’- ATC GAT TTT GCC CAA AAA GAA ATT AAC GGC GAT GAT 
GAC GAG GAC GAA GAT GAC GCG GAT AAC GTC ATG GCG GCC GAT GAT GAA 
AAT GCT TGA GGC GCG CCA CTT CT -3’ and pRL 66 were used. To make α7-Δ19 (S/D) 
that represents the phospho mimic (S258D, S263D and S264D), pRL320: 5’- ATC GAT TTT 
GCC CAA AAA GAA ATT AAC GGC GAT GAT GAC GAG GAC GAAG ATG ACG ACG 
ATA ACG TCA TGG ATG ACG ATG ATG AAA ATG CTT GAG GCG CGC CAC TTC T -3’ 
and pRL66 were used. All truncations and point mutations were confirmed by PCR followed by 
sequencing. To delete C-terminal last three amino acids from Rpt5 subunit, pRLS2-Rpt5: 5’- 
AAT ATG TAG ATA TGT GAA TGG CGG CTT GAT AAA TCA AAA TAT TAT TAT TTA 
TCG ATG AAT TCG AGC TCG -3’ and pRLS3-Rpt5-Δ3: 5’- TCG TTG AGG GTA TAA GTG 
AAG TTC AAG CAA GAA AAT CGA AAT CGG TAT CCT AGG GCG CGC CAG ATC 
TGT T -3’ were used. The templates used for the above PCR reactions indicated above were 
pFA61-3HA-kanMX6 (KAN) and pYM24 (HYGRO), primers were designed to eliminate the 3-
HA tags. 
Ecm29 promoter changes were done by using pRL194: 5’- TCT CCA CGA GCT GTT 
TTT CTT TCG CTT CGT CAG AAG AAA TGG A TC CGG AAT GGT GAT GGT GAT GGT 
GGT GCA TCG ATG AAT TCT CTG TCG -3’ and pfEcm29 Ntag s1: 5’- CAA TAA TTA 
TAG AAA AGT TTC TAT TTC ACC ACG AAC AAC ATT CGT ACG CTG CAG GTC GAC 
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-3’ with pYM-N15 to add GDP overexpression promoter. To add ADH weak expression 
promoter to Ecm29, pYM-N7 was used with pRL194 and pfEcm29-Ntag-s1. Integrations, 
truncations and mutations were confirmed by PCR and sequencing.  
 Antibodies used for immunoblots: 
Ecm29 and Rpn8 were detected using polyclonal antibody (generous gift by Dan Finley, 
Harvard Medical School, Boston, MA). Anti-α7 monoclonal antibody was purchased from Enzo 
Life Sciences and anti-Pgk1 monoclonal antibody was purchased from Invitrogen.  Peroxidase-
conjugated secondary antibodies were purchased from Jackson Immunoresearch Laboratories. 
 Proteasome purification 
Specific yeast strains were grown overnight in 2 to 3 liter of YPD media (final A600 ~ 
10.0). Cells were collected and washed with H2O. Pellets were resuspended in 1.5 pellet volume 
of lysis buffer (50 mM Tris [pH8.0], 5 mM MgCl2, 1 mM EDTA, and 1 mM ATP) and lyzed 
using a French Press at 1200 Psi. Lysates were cleared by centrifugation (10,000 g; 30 minutes) 
and the supernatant was filtered through cheesecloth. Concentration of cell lysate was measured 
using NanoDrop 2000 Spectrophotometer using the Protein A280 program and cell lysate 
equivalent to 50 mg of protein was boiled with 1X SDS-PAGE sample buffer for 5 minutes at 96 
ºC. Next, samples were resolved on 11% SDS-PAGE. For proteasome purification cell lysate 
were filtered through cheesecloth prior to incubation with IgG beads (MP Biomedical; 0.75 ml 
resin bed volume per 25 gram of cell pellet). After 1 hour of incubation (rotating at 4 ºC), IgG 
beads were collected in an Econo Column (Bio-Rad) and washed with 50 bed volumes of ice-
cold wash buffer (50 mM Tris [pH 7.5], 5 mM MgCl2, 50 mM NaCl, 1 mM EDTA, 1 mM ATP). 
Next, material was washed with 20 bed volumes of cleavage buffer (50 mM Tris [pH 7.5], 5 mM 
MgCl2, 1 mM DTT, and 1 mM ATP). Bead-bound proteasome complex was eluted by 
incubation with His-Tev protease (Invitrogen). The protease was removed by incubation with 
talon resin (Goldbio) prior to concentrating the proteasome complexes using 100 kDa 
concentrator (PALL Life Sciences). Purified proteasome were resolved on SDS-PAGE or on 
native gel as described previously 56. To store samples, 5% final concentration glycerol was 
added and samples were stored at -80 ºC.  
For core particle purification proteasome bound IgG beads were incubated with 5 bed 
volumes of wash buffer containing 500 mM NaCl for 1hr at 4 ºC under constant rotation. After 
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incubation, the beads were washed with 50 bed volumes of wash buffer with 500 mM NaCl. 
Elution and concentration of core particle complexes were as described above for proteasome 
complexes.  
Table 3.1 Yeast strains used for results in chapter-3. 
Strain          Genotype                                                                                    Figure        Ref. 
sUB61 MAT α lys2-801 leu2-3, 2-112 ura3-52 his3-Δ200 trp1-1 3.3A-B, 3.4, 
3.5A-D, B.1  
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sDL135 MAT α pre1::PRE1-TEV-ProA (HIS3) 3.2B, 3.2D 11 (a) 
sDL133 MAT α rpn11::RPN11-TEV-ProA (HIS3) 3.2B-C, 3.6B, 
3.7A, B.2B-C 
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sMK141 MAT α ecm29::TRP 3.3A-B, 3.4, 
B.1 
12 
sJR 211 MAT  α ecm29::TRP  rpn11::RPN11-TEVProA (HIS3) 3.9  
sJR544 MAT α ecm29::TRP rpt5::RPT5Δ3 (HYG) 3.3A-B, 3.4, 
B.1 
20 
sJR556 MAT A rpt5::RPT5Δ3 (HYG) 3.3A-B, 3.4, 
3.5C-D, B.1  
32 
sJR768 MAT α pre10::PRE10Δ40 (KAN) 3.3A-B, 3.4, 
3.5A-B, B.1  
(a, 
b) 
sJR770 MAT α pre10::PRE10Δ40 (KAN) pre1::PRE1-TEVProA 
(HIS3) 
3.2B, 3.2D (b) 
sJR 822 MAT  α ecm29::TRP   pre10::PRE10Δ40 (KAN) 
rpn11::RPN11-TEVProA (HIS3) 
3.9 (b) 
sJR805 MAT A pre10::PRE10Δ40 (KAN) rpt5::RPT5Δ3 (HYG) 3.3A-B, 3.4, 
B.1 
(b) 
sJR810 MAT α pre10::PRE10Δ40 (KAN) rpn11::RPN11-
TEVPro (HIS3) 
3.2B-C, 3.6B, 
3.7A, B.2B-C 
(b) 
sJR839 MAT A ecm29:: pGDP-H7-ECM29 (NAT) 3.5A-B (b) 
sJR840 MAT A pre10::PRE10Δ40 (KAN) ecm29:: pGDP-H7-
ECM29 (NAT)  
3.5A-B (b) 
sJR816 MAT  α ecm29:: pADH1-ECM29 (NAT) 3.5C-D (b) 
sJR820 MAT  α ecm29:: pADH1-ECM29 (NAT)  rpt5::RPT5Δ3 
(HYG) 
3.5C-D (b) 
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sJR884 MAT α pre10::PRE10Δ19(KAN) rpn11::RPN11-TEVPro 
(HIS3) 
3.6B, 3.7A, 
B.2B-C 
(b) 
sJR887 MAT α pre10::PRE10Δ19(S/A) (KAN) rpn11::RPN11-
TEVPro (HIS3) 
3.6B, 3.7A, 
B.2B-C 
(b) 
sJR887 MAT α pre10::PRE10Δ19(S/D) (KAN) rpn11::RPN11-
TEVPro (HIS3) 
B.2B-C (b) 
sJR912 MAT α pre10::PRE10Δ19 (KAN)  rpt5::RPT5Δ3 (HYG) 
rpn11::RPN11-TEVPro (HIS3) 
3.7B (b) 
sJR911 MAT α pre10::PRE10Δ19 (S/A) (KAN)  rpt5::RPT5Δ3 
(HYG) rpn11::RPN11-TEVPro (HIS3) 
3.7B (b) 
Ump1-
TAP 
MAT A ump1::UMP1- CBP-TEV-ZZ-(His3MX6) 3.8 (*, 
#) 
Ump1 Δ MAT α ump1::UMP1 (KAN)  3.3A-B, 3.4, 
B.1 
(*, 
#) 
sJR856 MAT α Ump1Δ (KAN) pre10::PRE10Δ40 (HIS3) 3.3A-B, 3.4, 
B.1 
(*, 
#, b) 
 
(a) PRE1 encodes for the proteasome subunit β4 and PRE10 for α7 
(b) this study 
* BY4741 background genotype (his3∆0 leu2∆0 met15∆0 ura3∆0). 
# Ref :  Ghaemmaghami, S. (2003) Global analysis of protein expression in yeast. Nature. 
425, 737-741 
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 Yeast phenotypes 
Indicated strains were incubated in 3 ml of YPD for overnight at 30 ºC. Next day, cells 
equivalent to 1.0 at OD600 were collected and washed with 100 µl sterile water. Cell pellet is then 
resuspended in 133 µl of sterile water and 4-fold serial dilutions were made in sterile water in 96 
well plate. Diluted cells were then spotted on the indicated plates and incubated at indicated 
temperatures. Growth was monitored for 3 days on YPD plates and for 5-6 days on synthetic 
media plates.    
 Fluorescent phospho- and coomassie blue staining 
10 µg Proteasome complex purified from the indicated samples were mixed with the 6X 
loading buffer and boiled for 5 minutes at 95 ºC. Boiled samples were cooled to room 
temperature and resolved on 11% SDS-PAGE gel. To detect the phosphorylated proteins, gel 
was subjected to fluorescent photo staining by using Pro-Q® Diamond phosphoprotein gel stain 
according to the manufacturer's recommendations (Life Technologies) and scanned with a 
Typhoon-9410 imager from Amersham Biosciences (excitation at 532 nm and an emission filter 
of 560nm longpass). After destaining, the gel was treated with Coomassie Blue and imaged using 
a Gbox image system (SynGene) with GeneSnap software. 
 Apyrase assay 
Equal amount of proteasome purified from the indicated strains were inhibited by 200 
nM proteasome inhibitor Epoxomicin in final volume and incubating at 30oC for 30 minutes. 
Both inhibited and non-inhibited proteasome samples are then subjected to apyrase treatment by 
adding apyrase (Sigma) in 0.024 mU/µl as final concentration diluted in apyrase buffer (50 mM 
Tris pH 7.5, 5 mM MgCl2, 0.25 mM ATP) and analyzed on nondenaturating gel. Dissociation of 
proteasome is monitored by in-gel activity assay using LLVY-AMC followed by 
immunoblotting with CP antibody α7.    
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 Results 
α7 subunit of CP as putative binding partner for Ecm29 
Ecm29 is predicted to bind CP as well as RP 11.  We hypothesized that the CP binding 
surface of Ecm29 should be in close proximity to RP binding site, Rpt5 12. Nevertheless, Ecm29 
is a large protein with a likely elongated and curved structure, thus the CP binding site does not 
necessarily have to be adjacent to Rpt5. Recent mapping of the RP-CP interaction and structural 
insights from several cryoEM structures of the proteasome provide a detailed understanding of 
the location of Rpt5 with respect to CP (Fig. 3.1A) 23-26. The C-terminus of Rpt5 docks into a 
pocket formed at the interface of the CP subunits α5 and α6 23-26 and has also been shown to be 
able to occupy the pocket between α6 and α7 23. The face of the CP cylinder provides the 
interaction surface with the RP. Here, the α-subunits have N-termini that extend and contributes 
to the formation of the CP gate 27. This area is unlikely to be available for Ecm29 binding, 
because it is covered by the RP in the 26S proteasomes 24-26. Thus, Ecm29 is more likely to bind 
to the side facing surfaces of α-subunits.  
 
Figure 3.1  α7 as the putative binding site for Ecm29. 
 
  
(A) CryoEM-based model of the Proteasome26 (PDB- 4B4T) showing regulatory particle (RP) 
and core particle (CP). Rpt5 is displayed in cyan and other Rpt subunits in blue. Lid subunits 
Rpn5 and Rpn6 that interact with the CP are shown in purple and the remainder of RP is shown 
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in green.  All core particle α subunits are colored in yellow, with the last three ordered amino 
acids of α7 shwon in red. β subunits are colored in orange. (B) Amino acids sequences from the 
α-ring subunits beyond crystal structure28 and model presented26. Second column shows the last 
three ordered amino acids for each α subunit. Third column shows C-terminal amino acids that 
were not resolved in the structure. Consecutive acidic residues in C-terminal of α7 residues that 
forms the acidic patch are underlined as red line. (C) Sequence alignment of acidic patch in the 
C-terminal tail of α7 from S. cerevisiae and H. sapiens. 
 
Interestingly, four out of seven α-subunits of the α-ring (α3, α4, α5, and α7) have C-
terminal amino acid sequences (≥10 residues) that are not resolved in the crystal structure of the 
CP and are likely to extend from the side face of the CP 28. From these α7 is particularly 
interesting because it contains the longest extension, 40 residues, and this region contains a patch 
of acidic residues (Fig. 3.1B). Human α7 has a similar C-terminal tail that extend beyond the 
crystal structure and harbors numerous acidic residues (Fig. 3.1C) 29. Thus, features of the α7 C-
terminal region are conserved from yeast to human. This is important since Ecm29 is conserved 
and presumably the binding site as well. Figure 1a shows the last resolved α7 residues in a 26S 
model in red. From this it is clear that the extended tail is in close proximity to the Rpt5 subunit 
(light blue in Fig. 3.1A) that we have previously shown to bind to Ecm29. 
 C-terminal tail of α7 subunit is important for Ecm29 binding to the proteasome. 
To test if the α7 C-terminal tail is important for the Ecm29-proteasome interaction, we 
deleted the last 40 amino acid residues from the α7 subunit (Fig. 3. 1A and 3.2a). These are all 
residues that were not resolved in the crystal structure of the CP 28. Strains with this α7 
truncation were viable and we refer to strains and proteasomes with this truncation as α7-Δ40 
from here onwards. To purify proteasomes we introduced this truncation in strains that either 
contained the protein A-tagged RP subunit Rpn1 or protein A-tagged CP subunit Pre1 (β4) 11.  
Compared with wild type proteasomes, proteasomes purified from these strains show a 
pattern on Coomassie Brilliant Blue (CBB) stained SDS_PAGE gels. (Fig. 3.2B). 
Immunoblotting for α7 showed a lower molecular weight for α7 upon truncation that was 
consistent with the expected reduction in molecular weight from 31.5 kD to 27.3 kD. Purified 
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proteasomes also showed a strongly reduced level of Ecm29 upon truncation of α7. As is evident 
from the CBB, proteasome preparations purified using the CP-tag have generally reduced levels 
of RP and increased amounts of CP as compared to RP-based proteasome purifications. This 
difference likely explains the lower levels of Ecm29 in CP-tag proteasome purifications. 
Nevertheless, there is still a clear reduction of Ecm29 levels upon deletion of the α7 tail.  
Native gel analyses of proteasome complexes purified from wild type and α7-Δ40 strains 
also showed reduced levels of Ecm29 in the α7-Δ40 background. Nevertheless, the remaining 
small amount of Ecm29 still bound to the same proteasome complexes as has been observed 
under wild type conditions, namely both singly and doubly capped proteasome (RP-CP and RP2-
CP, Fig. 3.2c). Additionally, we observed a slower migration form of CP in the α7-Δ40 samples. 
A similar slower migration of CP is observed when CP associates with Blm10. However, we did 
not observe increased levels of Blm10 in α7-Δ40 proteasomes compared to wild type 
proteasomes (Fig. 3.1B). The α7 truncation contains 16 acidic residues and the calculated 
isoelectric point of the protein changes from pI 5.02 to 7.72, thus instead of other proteins 
binding to CP, the altered migration might results from a difference in charge between wild type 
and α7-Δ40  CP. To test this we purified CP from wild type as well as from α7-Δ40 (Fig 3.2D). 
The high salt washes required to purify CP also removes any Blm10 that might be bound to the 
CP as is apparent from the absence of a ~240 kDa bands from CP preparations (Fig. 3.2D). Even 
in the absence of Blm10, α7-Δ40 derived CP showed a retarded migration compared to CP with 
full-length α7. Thus, the change in migration results from the truncation and is most likely due to 
the loss of negatively charged amino acid residues.  In sum, our results show that the truncation 
of the α7 tail leads to reduced binding of Ecm29 to singly and doubly capped proteasome. 
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Figure 3.2 unstructured C-terminal tail of the α7 is involved in the Ecm29 interaction to the 
proteasome. 
 
(A) Schematic representation of wild type α7 displaying the acidic patch (residues D250 to 
D259) and the α7 with C-terminal truncation (α7-Δ40) that removes all amino acids beyond 
N248. (b) Proteasomes were purified from wild type and α7-Δ40 cells using either an RP tag 
(Rpn11- TEV-ProA; left panel) or CP tag (Pre1-TEV-ProA; right panel) and analyzed on SDS-
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PAGE as well as by immunoblotting using antibodies against Ecm29 and α7. (B) RP-tag derived 
proteasome purifications from (B) were resolved on native gel and stained using an in-gel 
activity assay with LLVY-AMC as substrate in the presence of 0.02% SDS. Gel was coomassie 
stained or transferred to pvdf membrane to probe for the presence of Ecm29 and α7. (D) CP 
from wild type and α7-Δ40 cells was resolved on SDS-PAGE and stained with CBB (left panel). 
Same samples were also resolved on native gel, followed by in-gel LLVY-AMC activity assay and 
CBB staining. Difference in electrophoretic migration of CP from α7-Δ40 does not results from 
an enrichment in Blm10 and is likely due to the difference in charge between α7 and α7-Δ40. 
 
 Effect of α7 C-terminal tail truncation in vivo. 
Next, in order to determine the physiological importance of the α7 truncation in vivo, we 
analyzed cells for two phenotypes typical for proteasome mutants: sensitivity to heat stress at 37 
ºC and canavanine sensitivity. Both of these conditions are thought to introduce protein 
misfolding stress due to the high temperature or the incorporation of the arginine analog 
canvanine. Unlike several proteasome mutants or mutants with defects in proteasome assembly, 
the α7 truncation did not cause increased sensitivity to these conditions (Fig. 3.3A and 3.3B). 
This suggests there are no major defects in proteasome function upon deletion of the α7 C-
terminal tail. Similarly, the deletion of Ecm29 by itself does not cause temperature sensitivity or 
canavavine sensitivity.  
Next, we tested if the truncation can rescue or cause synergistic effects in backgrounds 
where this has been observed for the deletion of Ecm29. Here, we predict that strains with the α7 
C-terminal truncation should, at least in part, mimic phenotypes that resulted from a deletion of 
ECM29, because α7-Δ40 results in reduced binding of Ecm29 to proteasome. We have 
previously characterized the rpt5-Δ3 mutant where last three amino acids of the Rpt5 subunit are 
absent. In this strain proteasomes are enriched in Ecm29 20. The Rpt5 residues that are missing in 
rpt5-Δ3 strains, are involved in the docking of RP onto CP 23-26, 30. This suggests that 
proteasomes from rpt5-Δ3 cells have defects at the RP-CP interface due to improper association. 
Rpt5-Δ3 strain shows canavanine sensitivity resulting from the cumulative effect of reduced 
proteasome activity caused by the mutant form of Rpt5 as well as the inhibition by Ecm29 12. 
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The canavinine sensitivity can be rescued by a deletion of Ecm29. When we introduced the α7 
tail truncation in rpt5-Δ3 strains, the canavanine sensitivity was also rescued.  
The deletion of Ecm29 in an ump1Δ background causes increased sensitivity at 37 ºC 21.   
Ump1 is a CP assembly chaperone and the deletion of UMP1 has been results in defects in CP 
assembly as well as an enrichment of Ecm29 on proteasomes 21. The α7 C-terminal truncation in 
ump1Δ causes increased sensitivity of these cells for growth at 37 ºC, indicating the deletion of 
the 40 amino acids from the α7 causes a phenotype similar to the deletion of Ecm29 in this 
background as well. Thus, the α7 truncation phenotypically mimics a deletion of Ecm29, 
suggesting the α7 tail is important for the recruitment of Ecm29 to mutant proteasomes in vivo.  
Figure 3.3 α7 C-terminal truncation mimics as Ecm29Δ. 
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(A+B) Indicated strains were serially diluted (four-fold) and (A) spotted onto YPD medium and 
grown at the indicated temperatures for 3 days or (B) spotted on SD plates lacking arginine with 
or without canvanine and grown at 30 ºC for 5 to 6 days. The α7-Δ40 truncation resemble a 
deletion of ECM29 in the different backgrounds. 
 
Next, we biochemically characterized proteasome complexes formed in a mutant strains 
background. Cell lysates were resolved on the native gel followed by the activity assay using 
short peptide LLVY-AMC (Fig. 3.4). Singly and double capped proteasomes (RP2-CP or RP-CP) 
can associate with Ecm29. This association causes a slower migration on native gel 11, 13. Rpt5-
Δ3 cells are highly enriched in Ecm29 as compared to wild type cells. Consistently, more rpt5-
Δ3 proteasomes show a notably slower migrating species on the native gel, which is caused by 
association of Ecm29 as it is absent from ecm29Δ cells (Fig. 3.4 compare lane 3 and 5). 
Consistent with our phenotype data, truncations of α7 in the rpt5-Δ3 background caused a 
migration of the proteasomes on native gels similar to that resulting from the deletion of ECM29. 
This indicates a reduced recruitment of Ecm29 to α7-Δ40 rpt5-Δ3 proteasomes.    
To analyze the level of Ecm29 present in the different strains (Fig. 3.4 lower panel) we 
ran the same samples on SDS-PAGE and conducted western blot analyses using an antibody that 
can recognize the endogenous Ecm29 protein. As observed previously, the rpt5-Δ3 strain shows 
increased levels of Ecm29 in the total cell lysate compared to wild type. Interestingly, the 
truncation of α7 in this background reduces the levels of Ecm29 back to levels similar to wild 
type (Fig. 3.4, compare lane 6 with 1). Nevertheless, we did not observed any changes in 
expression of proteasome subunits.  Ecm29 has been reported to be degraded by the proteasome 
21, 22, which might suggest that a loss of interaction with proteasome increases Ecm29 turnover. 
However, other reports have suggested Ecm29 is stable and increased levels on proteasomes 
result from higher rates of transcription 15, which would suggest the α7 tail truncation results in a 
lower level of Ecm29 expression in this mutant.  In either case, the effect of the truncation of α7 
seems to be background dependent, as in both the ump1Δ and the ump1Δ α7-Δ40, Ecm29 levels 
are increased as compared to wild type.  
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Figure 3.4 Effect of α7 C-terminal truncation on Ecm29 expression level and its association 
to the proteasome. 
 
 
Equal protein amount of total cell lysates from the indicated strains were analyzed on 3.5% 
nondenaturing gel and stained using the LLVY-AMC activity assay (upper panel). Protein 
extracts were also resolved on SDS-PAGE, followed by immuno blotting to determine the levels 
Ecm29 and Rpn8. Immunoblot against Pgk1 was used as a loading control.   
 
To eliminate any complication in our analysis as a result of differences in transcriptional 
regulation of ECM29, we changed the promoter of ECM29 with the GDP promoter. For wild 
type cells this has been previously shown to increase the levels of Ecm29 in the cell and result in 
stoichiometric amounts of Ecm29 on proteasomes 12, 15 (Fig 3.5A and 3.5B). Under these 
conditions we see high levels of Ecm29 in the cell lysate of both wild type and α7-Δ40 cells. 
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Native gel analyses, however, clearly shows a reduced level of Ecm29 on 26S proteasomes from 
the α7-Δ40 strains, with singly capped proteasome having hardly any Ecm29 associated with the 
proteasome and strongly reduced amount of doubly capped proteasomes associated with Ecm29. 
Thus, even under conditions of very strong overexpression of Ecm29 the truncation of α7 causes 
reduced binding of Ecm29 to proteasomes. Since Ecm29 binds to Rpt5 in addition to α7, the loss 
of α7 binding probably results in a substantially reduced affinity of Ecm29 for proteasomes, but 
no complete loss of affinity. The high level of Ecm29 expression resulting from the GDP 
promoter might thus be able to still drive some Rpt5-mediated binding of Ecm29 to proteasomes, 
explaining some limited binding of Ecm29 to proteasomes in the α7-Δ40 background. 
 The ability to drive Ecm29 association with the proteasome by increasing the levels of 
Ecm29 in the cell, suggests that Ecm29 association with proteasomes is driven by the 
transcriptional regulation of ECM29 in the cell. However, we have previously shown that Ecm29 
shows better binding to a mutant proteasome as compared to a wild type proteasome 12. Thus, an 
alternatively explanation for the observation of Ecm29 on wild type proteasomes is that a lower 
affinity of Ecm29 for wild type proteasomes can be obscured by strong overexpression of 
Ecm29. Ecm29 levels resulting from GDP promoter are for example substantially higher than 
any increase resulting from upregulation of the endogenous locus through the stabilization of 
Rpn4. Thus, analyses from GDP promoter driven Ecm29 overexpression results are non-
physiological. Therefore, we created strains where Ecm29 expression is not driven by the very 
strong GDP promoter, but by the much weaker ADH promoter (Fig. 3.5C and 3.5D). Here, we 
still eliminate the Rpn4 feedback loop by replacing the endogenous promoter, but now have a 
much lower transcription level of ECM29. Consistent with this, there is less Ecm29 in the cells 
as compared to wildtype cells (Fig. 3.5C). That notwithstanding, the level of Ecm29 in the cell 
and on the proteasome dramatically increase in rpt5-D3 cells with the endogenous promoter as 
well as the ADH promoter.  Thus, clearly Rpn4 driven transcriptional upregulation is not 
required to achieve increased association of Ecm29 with mutant proteasomes.  
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Figure 3.5 Exchange of Ecm29 promoter to eliminate differential transcription of Ecm29.  
 
(A, B) The endogenous promoter of Ecm29 was replaced with the GPD promoter. This exchange 
causes a strong overexpression of Ecm29 that drives binding of Ecm29 to all most all wild type 
proteasomes12, 15, as is seen in the immunoblot of total lysates. Native gel analyses of total lysate 
can visualize presence of Ecm29 on singly and doubly capped proteasomes because the presence 
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of Ecm29 causes a migrational shift. The presence was also confirmed by immunoblotting the 
native gel and probing with an anti-Ecm29 antibody. Even under conditions of strong 
overexpression the α7-Δ40 strain shows strongly reduced levels of Ecm29 on singly and doubly 
capped proteasomes. (C, D) The endogenous promoter of Ecm29 was replaced with the ADH 
promoter resulting in weak expression of Ecm29 in wild type as well as in rpt5-Δ3 strain 
background. Analyses were identical as for (A, B). With weak promoter the behavior of Ecm29 in 
wildtype and mutant strains is very similar to cells with the endogenous promoter, suggesting the 
Rpn4-dependent transcriptional regulation of Ecm29 is not essential for the enrichment of 
Ecm29 on proteasomes. 
 
 α7 phosphorylation is required for Ecm29 interaction to CP. 
Seven phosphorylation sites have been identified in yeast α7 31-36. Interestingly, five of 
these sites, S258, S263, S264, T278 and T279, are present in the tail of the α7 that we 
eliminated. From these, S258, S263, and S264 have been identified multiple times and in studies 
specifically focused on phosphorylation of the proteasome 31, 33, 34, 37. The phosphorylation of α7 
has been observed in humans as well, suggesting there is a conserved function for this 
modification 38-40. CK2 (formerly known as casein kinase 2) has been proposed to be responsible 
for phosphorylation of the serine residues present at the α7 C-terminal 31, 41. CK2 generally 
phosphorylates serine residues in an acidic environment 42, which is provided by the acid patch 
present in α7 tail. Furthermore, the phosphorylation by CK2 is often constitutive. This is 
consistent with the observation that yeast as well as human α7 is present almost exclusively in 
the phosphorylated form 37. To test if α7 is phosphorylated under our conditions, we purified 
proteasomes and resolved preparations on SDS-PAGE. Gels were stained for CBB and analyzed 
using the in gel Pro-Q diamond phosphostain. These analyses show a band corresponding to the 
size of α7 that is strongly phosphorylated. Consistent with our assignment of α7, this band 
disappears in the phospho-stain analyses when analyzing proteasomes from the α7-Δ40 strain. 
Since no band of lower molecular weight appeared, our data suggest that α7 is mainly 
phosphorylated in the C-terminal fragment, something that had been suggested before 37. To test 
if T278 and T289 in α7 are essential for the ability of Ecm29 to bind proteasomes, we eliminated 
these phosphorylation sites by making a truncation that removes only 19 residues instead of 40 
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from α7, keeping the acidic patch and three serine phosphorylation sites intact, namely S258, 
S263, and S264. We refer to this mutant as α7-Δ19 (Fig. 3.6A). We tested the cell lysates from 
the mutated strains if that affects the Ecm29 expression. Elimination of last 19 amino acids from 
the C-terminal tail of the α7 does not affect the Ecm29 level in vivo (Fig. 3.6B). 
Figure 3.6 Phosphomutations at the C-terminal tail of the α7 and Ecm29 expression level. 
 
 
 (A) Schematic representation of mutations in α7 protein. A short truncation at the C-terminal 
tail of the α7 were made resulted in α7ΔC-ST (1-269) that contains acidic patch and three serine 
phosphorylation sites (S258, S263 and S264). Phosphomutant α7ΔC-ST (S/A) were created by 
replacing three serine residues with alanine. (B) Equal amount of protein extracts from indicated 
strains were analyzed on immunoblot. Ecm29 level in each extract from indicated strains were 
observed using Ecm29 antibody and Pgk1 as loading control. 
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Proteasomes purified from an α7-Δ19 strain show a band of the expected size on the 
phospho-stain gel, indicating that the remaining phosphorylation sites are still phosphorylated 
(Fig. 3.7A right panel). The levels of Ecm29, as determined by immunoblotting, are similar to 
the levels of Ecm29 found associated with wild type proteasome (Fig. 3.7A left lower panel). 
Thus, the Ecm29 binding is mediated by the fragment of the α7 tail that contains the acidic patch 
and the serine phosphorylation sites. To test the importance for phosphorylation of these serine 
residues, we introduced serine to alanine mutations into the α7-Δ19 background. The strains with 
all three serine residues mutated to alanine (S258A, S263A, S264A) is referred to as α7-Δ19 
(S/A). Proteasomes purified from α7-Δ19 (S/A) cells showed no detectable phosphorylation of 
α7 in our phospho-stained gel assay. Interestingly, these proteasomes showed dramatic reduction 
in the amount of Ecm29, having levels similar to those on α7-Δ40 derived proteasomes. Thus, 
the binding of Ecm29 to requires the phosphorylation at serine residues in the tail of α7.  
Figure 3.7 Binding of Ecm29 to proteasomes depends on the phosphorylation of the C-
terminal tail of α7. 
 
A B 
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(A and B) Proteasome complex were purified from the indicated strains and equal amount of 
purified proteasome were analyzed on the SDS-PAGE as well as on immunoblot.  Ecm29 on the 
purified proteasomes were identified that shows weak association with the proteasome 
containing α7 phosphomutants both in wild type as well as in proteasome from rpt5-Δ3 (left 
panel in A and B).  Phosphorylation of α7 in indicated strains were also confirmed by using Pro-
Q Diamond phosphoprotein gel staining protocol from Thermo Fisher Scientific. Rpn8 level that 
served as loading control in all purified proteasome samples were detected using Rpn8 antibody.  
 
It is currently unclear if the binding of Ecm29 to mutant proteasomes relies on 
fundamentally different proteasomal binding sites or that Ecm29 utilizes the same binding sites 
for binding to wild type and mutant proteasomes. To test this for the phosphorylated α7 tail, we 
introduced the α7-Δ19 (S/A) mutant in the rpt5-Δ3 background. Upon purification of 
proteasomes we observed that the mutation of the serines in the rpt5-Δ3 background still leads to 
reduced levels of Ecm29 on proteasomes. Thus, the recruitment of Ecm29 to faulty proteasomes 
relies on the ability of Ecm29 to bind to CP as well as RP (Fig. 3.7B). 
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 Discussion 
Many sites of post-translational modification have been identified on the proteasome, 
including phosphorylation of several core and regulatory particle subunits 43. Some functions for 
proteasome phosphorylation have emerged, like an enhanced degradation of substrates 44, 45, 
regulation of proteasome activity in a particular compartments 46, or regulation of proteasome 
assembly or stability 47. While the mechanisms are often unclear, the phosphorylated residues of 
proteasome subunits have been proposed to (directly) regulate the proteasomal ATPase activity, 
state of the CP gate, or the proteolytic active sites. For example, it has been suggested that 
phosphorylation of the α7 tail leads to a conformational change resulting in the closure of the CP 
gate 43. Here, however, we report that the phosphorylated tail of α7 serves as a binding site for 
the proteasome-associated factor Ecm29. For most proteasomal phosphorylation events it 
remains unclear how it affects proteasome function and this is one of the first examples where 
the association of a proteasome interacting proteins depends on a phosphorylated proteasome 
subunit.  
Often phosphorylation is a transient modification that has a local effect for a limited 
period of time. Consistently, the phosphorylation of a particular site is labile and normally found 
only a fraction of all proteasomes carry that modification. Both in human and yeast, however, the 
phosphorylation of the proteasome α7 subunit appears to be constitutive, readily detectable, and 
present on >95% of the α7 subunits37. Ecm29, on the other hand, is only found on a 
subpopulation of proteasomes, suggesting that the phosphorylation of α7 is not the distinguishing 
factor that determines which proteasomes bind Ecm29.  
Instead of being a trigger that creates a binding site for Ecm29, α7 appears to provide a 
pre-requisite for binding. Consistent with this model, the kinase that likely phosphorylates α7, 
CK2, is a constitutive kinase with many substrates in the cell 31, 41, 42. CK2 phosphorylation has 
e.g. also been proposed to be a prerequisite for the UBC3 binding to the F-box receptor β-TrCP 
48. CK2 is normally not activated in response to signals leading to a transient phosphorylation, 
but appears to provide a continuous global signal. Through this, in theory, CK2 could be 
communicating to many different pathways and processes that e.g. there are high energy levels in 
the cell. Therefore, to identify functions of α7 phosphorylation it will be crucial to either identify 
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a phosphatase responsible for the removal of the phospho groups and determine when that is 
activated, or identify a cellular condition where the phosphorylation is reduced.  
An important role for a phosphatases in regulating proteasome function has been reported 
previously, with UBLCP1 regulating nuclear proteasomes 46. The absence or removal of 
phosphorylation might ensure that no Ecm29 will bind to the proteasome. Thus, the 
identification of such conditions will inform us when it is important to prevent Ecm29 from 
binding to proteasomes. We speculated that Ecm29 binding to immature CP might be 
undesirable as Ecm29 is normally only found on mature assembled proteasomes. However, when 
we purify immature CP using the Ump1-TAP tag 5 we observed that α7 is already 
phosphorylated in the stage of the assembly process where Ump1 binds to immature CP (Fig. 
3.8).  
Figure 3.8 α7 in immature CP is already present in phosphorylated form.  
 
Immature CP was purified using TAP affinity tag on Ump1 and analyzed on the SDS-PAGE and 
strained with CBB as well as with Pro-Q-Diamond phosphostain.  
 
 While our data show that the phosphorylation of the α7 tail is important for association of 
Ecm29 with proteasomes, it is unclear if that is the only function of the phosphorylated tail of α7. 
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Previous studies have reported that in humans the phosphorylation of α7 is important for 
regulating the stability of the CP-RP interactions 40. Interestingly, Ecm29 binds to the RP subunit 
Rpt5 in addition to the α7 subunit and has been shown to stabilize the CP-RP interaction as well 
12, 13, 20. This Ecm29-dependent stabilization is particularly striking in the absence of nucleotide, 
where yeast proteasomes would dissociate otherwise. In the absence of Ecm29 a similar 
stabilization can be achieved by treating proteasomes with proteasome inhibitors. This indicates 
an allosteric pathway from the CP active sites to the RP-CP interface exists.  The tail and 
phosphorylation sites of α7 are not responsible for this stabilization in the absence of Ecm29, as 
α7-Δ40 proteasomes still show proteasome inhibitor stabilized CP-RP (Fig. 3.9). Thus, it remains 
to be determined if α7 can stabilize CP-RP directly as well as through Ecm29.  
The α7 tail might also serve to bind or recruit other factors besides Ecm29. Several 
proteins have been reported to bind to α7, like some of the ubiquitin-independent proteasome 
substrates 49, 50. The role of the C-terminal tail here remains to be clarified.  
As predicted during the initial identification of Ecm29 as a proteasome associated protein 
in 2001, Ecm29 binds to both RP and CP 11, 12. The identification of these sites provides an 
important clue towards the mechanism of Ecm29 recruitment to specific proteasomes. 
Nevertheless, we do not fully understand why Ecm29 is present in substoichiometric amounts on 
wild type proteasomes, but is highly enriched on a variety of proteasome mutants. Here, Ecm29 
does not appear to compensate for defects by stabilizing proteasomes, but instead to specifically 
bind and inhibit them 12, 15, 20. Phenotypically, the effect of deleting Ecm29 is rather pleotropic, 
suggesting it has multiple functions in the cell or becomes a dominant negative factor under 
certain conditions. Eitherway, the mechanisms responsible for enrichment of Ecm29 on mutant 
proteasomes are still poorly understood. 
Three models have been put forward; First, Rpn4-dependent enrichment 15. In this model, 
reduced proteasome activity as results of a mutation in the proteasome subunits leads to the 
accumulation of the unstable transcription factor Rpn4 51. Rpn4 recognizes the PACE element 
found in promoter of many proteasome subunit as well as Ecm29 52. As a result both proteasome 
subunits and Ecm29 are upregulated, however, Ecm29 upregulation is stronger thereby causing a 
relative increase in Ecm29 as compared to proteasomes 15. Since we observed Ecm29 enrichment 
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on mutant proteasomes in strains where the endogenous promoter was replaced by the ADH 
promoter (Fig. 3.5C), it is clear that this mechanism is not required for proteasomal enrichment 
of Ecm29. That said, it might be a contributing factor.  
Figure 3.9 RP-CP stabilization is not affected with the α7 C-terminal truncation. 
 
Proteasome purified from indicated strains were inhibited by Epoxomicin and then subjected to 
apyrase treatment. Dissociation of proteasome is monitored on nondenaturing gel by in-gel 
activity assay using LLVY-AMC followed by immunoblotting with CP antibody α7.    
 
The second model proposes a high affinity of Ecm29 for mutant proteasomes 12. This 
model is consistent with our observation that strong overexpression of Ecm29 can compensate 
for a weaker affinity and drive proteasomal binding of Ecm29 to normal proteasomes. However, 
weaker promoters, like the ADH promoter, prevent this and thus result in an almost exclusive 
77 
accumulation of Ecm29 on mutant proteasomes. Although we lack the molecular insight into a 
mechanism that would allow for such a difference in affinity, it might involve the alignment of 
CP relative to RP.  
The interaction between CP and RP has some flexibility as the tails of Rpt5 subunits has 
been detected to interact with CP at different positions 23. Furthermore, many mutants that 
accumulate Ecm29 are linked to RP-CP interactions, either direct or indirectly 12, 20, 21, 30. Now, 
we have shown that Ecm29 binds to specific subunits on both RP and CP. Thus, any rotational 
flex in the CP-RP binding interface will likely change the relative position of these two binding 
sides, thereby potentially creating optimal and suboptimal binding position depending on the 
distance or angle between the two binding sites. Such a difference can be the basis of a 
difference in affinity.  
Alternatively, a higher affinity of Ecm29 to proteasomes could be induced by local 
changes in the structure, e.g. if a mutation of the Rpt5 subunit changes the shape directly or 
through affecting the nucleotide occupancy of Rpt5. Then, if Ecm29 has a higher affinity for that 
changed surface, it causes a higher affinity. For the later, the higher affinity of Ecm29 resulting 
from RP mutations would not depend on the ability of Ecm29 to bind CP. Our data, however, 
show the enrichment of Ecm29 on RP-mutant proteasomes still depends on the ability of Ecm29 
to bind to the phosphorylated α7 tail. Therefore, we propose that an ability of Ecm29 to detect 
differences in RP-CP alignment is the basis for the better binding to mutant proteasomes. 
The difference in affinity cannot by itself explain all our observations. In particular the 
striking difference in cellular Ecm29 levels in ADH promoter driven Ecm29 in mutant versus 
wild type cell (Fig. 3.5C). Since, Ecm29 is controlled from the same promoter, differences in 
cellular level of Ecm29 most likely result from differences in degradation of Ecm29. Consistent 
with the third model, Ecm29 enrichment based on differences in degradation rate. This model 
proposes that Ecm29 is degraded by the proteasome. Hence, any defects in proteasome function 
result in stabilization of Ecm29 and a subsequent enrichment of Ecm29 on proteasomes. Indeed, 
Ecm29 has been shown to be degraded 21, 22, although others have reported it to be stable 15. 
While this model is simple and elegant, it is complicated by our observations that Ecm29 inhibits 
proteasomes, suggesting it would prevent its own degradation. It could be that depending on 
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which proteasomes Ecm29 binds to (wild type or mutant), internal disordered regions are more 
or less accessible for engagement by the proteasome. Availability of such regions can 
dramatically change protein half-life53. 
In sum, our data show that phosphorylation of the tail of α7 is a prerequisite for the 
binding of Ecm29 to proteasomes. While this suggest that this interaction is regulated by 
phosphorylation, it remains to be identified, which conditions lead to the dephosphorylation of 
α7 and thus the regulation of Ecm29 binding through phosphorylation.  
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Protein homeostasis in the cell is maintained by balancing protein synthesis and protein 
degradation. Protein synthesis is necessary to make new proteins in order to drive variety of 
biochemical reactions in the cell. Once synthesized as a nascent polypeptide chain, protein goes 
through numerous steps of not only structural modifications to form three dimensional active 
conformation but also through a quality control process assisted by chaperones. The quality 
control factors (e.g. Heat shock proteins: Hsp70, Hsp40 and Hsp104) here through its interaction 
with the polypeptide, assisting protein folding into the shape that can carry out necessary 
biological functions. However protein misfolding can occur and misfolded proteins go through 
multiple refolding attempts. Proteins that fail to be properly folded or proteins that forms 
aggregates are eliminated through the protein degradation process1. Besides misfolded proteins, 
properly folded proteins can also needed to be degraded. Here, the removal of such proteins is an 
important part of the regulation of biological processes. Hence, protein degradation is important 
not only for the clearance of the unwanted proteins, but also for the timely removal of functional 
proteins.  
The ubiquitin-proteasome system is responsible for clearing of many proteins. The 
proteins are first tagged with ubiquitin and then degraded by the proteasome. The Proteasome is 
made up of 33 unique polypeptides that need to assemble precisely to form this complex 
molecular machine. At least ten assembly chaperones are required to make the proteasome 
assembly process efficient and accurate. Similar to the protein quality control required for 
protein folding, proteasome assembly also goes through quality control. Here, one of the function 
of the proteasome pre-assembly quality control is to assure accurate and efficient proteasome 
formation with the help of assembly chaperones by avoiding premature assembly intermediate 
formations. If the defective proteasome is formed, quality control process detects the defective 
proteasomes possibly for their clearance2. The research work presented in this dissertation 
describes one of such mechanism of pre-assembly quality control that occur during core particle 
(CP) assembly as well as uncover mechanistic steps involved in the post-assembly quality 
control of the proteasome by quality control factor Ecm29. We found that the phosphorylation of 
CP subunit α7 is a prerequisite for Ecm29 binding to proteasome. 
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 Pre-assembly quality control during CP assembly 
  
CP is the most abundant form of the proteasome subcomplex present in the cell compare 
to other subcomplexes. The regulated activation of the CP for substrate degradation is a key 
mechanistic feature of the proteasome. Because CP can interact with many CP interacting factors 
(CPIFs) either at one or both ends of the CP there is an additional layer of proteasome regulation. 
In yeast four such factors are known, namely RP, Pba1-Pba2 (PAC1-PAC2 in human), Blm10 
(PA200) and Fub1 (PI31). Interestingly all four CPIFs are attached to the CP through their direct 
interaction with α-ring. Here, a C-terminal three amino acids HY-b-X motif found in all these 
factors is important as it docks into pocket formed between α subunits3,4.  However, their 
interaction to the CP has varied effect on regulation of CP activity. Moreover, these interactions 
occurs at different assembly stages of CP. For example, Pba1-Pba2 associates with immature CP, 
Blm10 associates with immature as well mature CP, RP is mostly found associated with mature 
CP, and Fub1 is also associated with mature CP5. Since all the CPIFs share the same seven 
subunits α-ring as CP interacting surface, it is crucial to elucidate how the timely interactions of 
these CPIFs with CP is regulated and controlled. This is also important in a sense that various 
stress conditions affects the dynamics of the type of proteasome complexes formed, moreover 
this dynamic is also specific to the cell types6. 
The work presented in this thesis sheds light on one of the mechanism that regulates the 
interactions between CP and two CPIFs. Here, we reported the regulation of interactions between 
Pba1-Pba2 and RP with immature CP (CP assembly intermediate) and mature CP (20S). In order 
to analyze these interactions we purified CP assembly intermediate.  Presence of CP assembly 
chaperone Ump1 is a hallmark of the immature CP where β7 subunit has not yet been 
incorporated and proteolytic β subunits are still inactive. We were able to purify sufficient 
amount of immature CP for the analysis by adding TAP-tag on the Ump1. This was likely 
facilitated by a slower maturation of CP due to the bulky TAP tag on Ump1. Consistent with 
this, immature CP purified using the Ump1-TAP tag lacked the β6 besides the β7 subunit that is 
normally absent from immature CP. This slower CP assembly process enabled us to capture 
immature CP in a large amount. We observed Pba1-Pba2 almost exclusively on immature CP, 
when purified proteasome complexes from yeast. Previous reports hypothesized a role for Pba1-
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Pba2 in α-ring assembly as well as the prevention of α-ring dimerization7. We further investigate 
the role of pba1 and Pba2 heterodimer with regards to its proposed role in blocking RP during 
CP maturation. We observed the interaction of RP subunits with the immature CP in the absence 
of Pba1 and Pba2. Moreover amount of RP associated with immature CP was modestly increased 
upon additional knockout of Blm10 showing Pba1-Pba2 prevents RP to prematurely associate 
with CP intermediates.  
 Blm10 and its affinity with immature and mature CP. 
During analysis of the immature and mature CP in the absence as well as in the presence 
of Pba1-Pba2 complex we observed that Blm10 has similar binding affinity with the immature 
and mature CP. Interestingly Blm10’s C-terminal HY-b-X motif uses same pocket (α5-α6) on α-
ring as Pba1 on immature CP α-ring and Rpt5 on mature CP8. Therefore it is not fully understood 
how the regulation of such competitive binding is achieved in the cell. Blm10 has been suggested 
to help during CP assembly9 and also shown to help in localization of proteasome to the nucleus. 
Blm10 can also locate the Blm10-CP in proteasome storage granules under certain physiological 
stress conditions10. Moreover it promotes the degradation of specific substrates. Thus, suggesting 
that Blm10-CP association is physiological state specific and has some specificity towards 
substrates11. However the mechanism of selection of Blm10 over RP for CP interaction remains 
obscure.     
 Crystal structure of immature CP.  
Affinity switch described in this thesis was recently complimented by the cryoEM studies 
of 15S and 20S complex12. We showed that the higher affinity of Pba1-Pba2 to the immature CP 
than mature CP contributed through the C-terminal tail of the Pba2.  The cryoEM structure also 
displayed the significant differences in docking of Pba2 onto immature CP vs mature CP. 
Additionally, the slight conformational changes in the α-ring has been noted during CP 
maturation. However, this study lacks the resolution particularly with respect to detailed 
interactions of Pba2 with the α-ring pocket residues. Hence, high resolution crystal structure of 
immature CP with Pba1-Pba2 is needed. The previously described crystal structure is from 
reconstituted Pba1-Pba2 on mature CP. Since the mature CP in vivo does not associate with 
Pba1-Pba2, this diminishes the physiological importance of the existing crystal structure model 
with mature CP. Crystal structure of immature CP with Pba1-Pba2 will further elucidate the 
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detailed changes responsible for the affinity switch that occurs upon CP maturation . This will 
improve our knowledge in terms of both CP α-ring configuration and its effect on the Pba2 
interaction with the α6-α7 pocket residues. It will provide insights for Blm10-mature/immature 
CP interactions. Since Blm10-mature CP crystal structure is available13, direct comparison of α-
ring from both structures might be helpful.   
 Fate of immature CP-RP complex 
The mathematical modeling presented in chapter 3 suggests that the formation of these 
immature CP-RP complexes can act as a deadlock to the proteasome assembly process and will 
hinder the efficiency of proteasome formation. The fate of these immature CP-RP complexes is 
yet to be clarified. Interestingly, we have observed the presence of Ecm29 on these complexes. 
Ecm29 has been known to perform a quality control function by binding to the defective 
proteasomes through its interaction with RP as well as CP together. It will be interesting to study 
if Ecm29 has any role in regulation of these complexes and possibly help in their clearance from 
the cell though any autophagic processes.  
 CP formed in the absence of Pba1-Pba2 complex.   
Our 2D gel analysis indicated that in the absence of Pba1, CP formation is delayed due to 
slow incorporation of α5 and α6. However Pba1 knockout does not show any severe phenotypic 
growth effect in yeast14. Nevertheless, in mammals PAC1 knockout mice shows early embryonic 
lethality indicating its role in the development. The conditional knockout mice also showed 
severe phenotype including deformation of brain structure and substantially reduced proteasome 
activity in the brain15. Here, PAC1 knockout does not cause complete loss of the 20S CP. 
Overall, this suggests that CP formation ultimately takes place and Pba1-Pba2 independent 
pathway might be present. The question remains to be answered that is there any difference in 
CP formed in the presence and in the absence of Pba1?   
We suspect that apart from delaying the CP formation, Pba1-Pba2 may have additional 
biological function in CP maturation and CP formed in Pba1 independent manner can be 
different. We have noticed enrichment of Blm10 on the CP when proteasome is purified from the 
Pba1Δ background. With the notion that Blm10 used the same pocket as Pba1 to interact with 
CP, two models can be proposed. First, blm10Δ can function as redundant protein in the absence 
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of Pba1 and as previously proposed can help in CP maturation9. However its role in maturation is 
still a matter of debate since CP can form in pba1Δ blm10Δcells and yeast does not show any 
phenotype. Second, CP formed from pba1Δ may have different conformational α-ring surface 
that favor Blm10 binding than RP and hence the enrichment.   
Figure 4.1 CP subunits comparison between CP from wt and from Pba1Δ 
 
 CP from wt and pba1Δ strains were purified and analyzed by IEF followed by SDS PAGE. 
Indicated CP subunits in wt are identified using mass spec. The proteins spots in case of Pba1Δ 
CP were assigned based on wt gels. Additional spots found on Pba1Δ CP gel need to be 
identified.   
 
We purified CP from wt yeast as well as from Pba1 knockout and analyzed it on 2D gel 
(preliminary data). Some additional protein spots in Pba1Δ CP were observed those absent in wt 
CP (Figure 4.1). These extra spots can either be modifications of CP subunits or proteins that 
remains associated with the CP during Pba1-Pba2 independent assembly. Further confirmation 
and analysis of these proteins through mass spectrometry will reveal if the CP formed is different 
or the same.  
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 Post-assembly Quality control 
The work in this thesis improves our knowledge on the Ecm29 interactions with the 
proteasome. We previously identified RP subunit Rpt5 that interacts with the Ecm29 and the 
current work reported here shows that the CP subunit α7 phosphorylation is required for the 
Ecm29 binding. However this does not fully answer how Ecm29 recognizes the proteasome. The 
constitutively active CK2 in mammals has been reported to phosphorylate α7, suggesting that α7 
might be always phosphorylated16,17. Considering Ecm29 as a quality control factor that 
recognizes defective proteasome, additional biochemical analyses are required to understand the 
mechanism behind the recruitment of Ecm29 to proteasome. Identifying residues on Ecm29 that 
interacts with proteasome might be helpful if there are any interaction differences when Ecm29 
is associated with the normal proteasome vs mutant proteasome.  
 Possible interaction sites on Ecm29 
Ecm29 is a large protein with molecular weight around 210Kda and difficult to purify. As 
a result, limited structural information is present. The only available EM images are of low 
resolution and provide little information concerning the detailed interactions18. Alternative 
strategies can be used to tackle these challenges. We used the structure prediction program 
Phyre2 and generated the putative structure of the Ecm29 based on yeast Ecm29 amino acids 
sequence (Figure 4.2). The predicted structure shows a curved nature of the protein consistent 
with the EM structure. This structure prediction of Ecm29 can be used to predict potential 
interaction surface. For example, the electrostatic surface potential from this structure shows 
cluster of charged residues that can be favorable to interact with CP and RP (Fig. 4.2B). 
Alternatively, several mutated or truncated protein versions can be created and possible binding 
domain can be analyzed. Additionally, Phosphorylation sites (Ser1396 and Ser1695) on the 
Ecm29 has been identified19 those have casein kinase 1 motifs. Involvement of phosphorylation 
dependent interaction can be tested by creating phoshomutants.      
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Figure 4.2 Predicted structure from amino acid sequence of yeast Ecm29 using Phyre2 
program. 
 
(A) Online Phyre2 program was used to predict the structure of Ecm29. The predicted structure 
shows elongated and curved molecule consistent with the most HEAT repeat motif containing 
structures. (B) The electrostatic surface potential of the Ecm29. Blue color indicates positive 
charge and red color indicates negative charge surface whereas white color indicates neutral 
charge surface. The polar residues hot spots at the Ecm29 surface can be a potential interaction 
sites to the proteasome. (C and D) unstructured linker regions on Ecm29 (circled) can provide 
flexibility to the Ecm29 to interact with variety of misaligned proteasome complexes.   
A B 
C D 
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 Specificity of Ecm29 for mutant proteasomes 
Our results with the over-expression of Ecm29 show that Ecm29 can be associated with 
the wild type proteasome when present in excess. However, we previously observed that Ecm29 
preferably interacts with mutant proteasome (Rpt5-Δ3) over wild type proteasome if Ecm29 is 
under the control of the endogenous promoter20. This raises the question how Ecm29 recognizes 
mutant proteasome over wild type proteasome? One prediction would be that mutation in the 
proteasome might result in the changes in the alignment of the RP and CP structures. This can be 
due to either improper docking of the RP subunit tails into the pockets between α subunits or 
changes in proteasome subunits conformation due to mutation. This changed alignment might 
favor the Ecm29 binding to mutant proteasome over normal proteasome. Misaligned 
conformation might lock the RP ATPase subunits in specific nucleotide state that use different 
word Ecm29 interaction to the proteasome. This model is consistent with our observations that 
Ecm29 is more abundant on the proteasome purified in the presence of AMP when compared in 
the presence of ATP. Alternatively, additional factors might be involved in the recognition of 
defective proteasome. One such factor is Not4, an E3 ligase whose absence has shown to disturb 
the Ecm29 interaction with the proteasome21. However, the Not4 dependent interaction did not 
show any specificity for the mutant proteasome. Further experiments are needed to explore 
specificity for mutant proteasome recognition process through Ecm29.  
 Post-translation modification of the proteasome subunits and regulation of 
proteasome activity in disease conditions. 
To our knowledge the CP α7-subunit phosphorylation dependent interaction of Ecm29 is 
the first example for a role of proteasome subunit posttranslational modification in regulating the 
interaction with associated proteins. Many posttranslational modifications have been reported for 
proteasome subunits such as oxidative modifications, ubiquitination, N-acetylation, N-
myristoylation, phosphorylation, and glycosylation22. While some modifications have been 
proposed to regulate proteasome activity, proteasome translocation to the specific compartments, 
or RP-CP stability1,23. Most of these data are derived from the large proteomic analyses and lack 
biochemical and cell biological studies that could reveal the physiological function of these 
modification. Furthermore, some of the function proposed to be a direct consequence of the PTM 
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actually could result from changes in the presence of proteasome-associate proteins, which are 
known to regulate these functions.  
 Many proteins have been identified which are not classified under group of proteins 
related to the ubiquitin proteasome pathway (proteasome associate proteins), but their direct 
interaction with the proteasome has been studied biochemically. For example a tumor suppressor 
retinoblastoma protein pRb has been shown to directly interact with α7 subunit. A misfolded PrP 
protein has been suggested to regulate the CP activity by direct interaction with CP from the 
outer side of the CP cylinder. Parkinson associated protein Dj1 also physically interact with the 
20S proteasomes24-28. More in detail studies are required to know if interactions of all these 
proteins to the CP are dependent on the posttranslational modification of the proteasome subunits 
which can add an extra layer of regulation of proteasome activity during various disease 
conditions.  
Figure 4.3 Model of quality control mechanism during pre-assembly and post-assembly of 
the proteasome. 
  
Figure 4.3 summarizes our finding about overall quality control in the proteasome. Chaperones 
functions as a pre-assembly quality control to avoid the formation of nonproductive deadlock 
assembly intermediate complexes and assures the efficient and accurate proteasome formation. If 
the assembled proteasome is defective then Ecm29 recognizes the mutant/defective proteasome 
and inhibit it to avoid the aberrant protein degradation.  
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Appendix A - Supplementary Information for Chapter 2 
Figure A.1 Supporting data related to Figure 2.1 Pba1-Pba2 prevents RP association with 
immature CP  
 
 
(A) Proteasome from strains deleted for PBA1 or PBA2 shows increased levels of Blm10. 
Proteasomes were purified from indicated strains using an affinity-tag on the β4 subunit. 
Samples were resolved on SDS-PAGE and stained with CBB. In this preparation some Blm10 
was cleaved at the N-terminus, causing the presence of a second faster migrating species of 
Blm10. (B) Pba1-Pba2 antibody recognizes Pba1 and Pba2. GST-tagged Pba1 and His-tagged 
Pba2 were co-expressed in E.coli and purified using glutathione resin. Protein dimer was eluted 
using Precission protease, which cleaved between GST and Pba1. The purified protein was used 
to raise antibody against Pba1-Pba2. Immunoblot using the serum (#1940) from immunized 
rabbit showed the antibody recognizes both Pba1 and Pba2. (C) Deletion of Blm10 does not 
cause an accumulate RP on immature CP. Immature CP from indicated strains was purified 
and resolved on SDS-PAGE followed by immunoblotting for indicated proteins. The enrichment 
in RP (Rpt1 blot) on immature CP observed for pba1Δ strains was not observed upon deletion of 
BLM10.  
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Figure A.2 Supporting data related to Figure 2.2 CP undergoes affinity switch upon 
maturation. 
 
 
 
(A). Binding kinetics for the interaction between CP and the Pba1-Pba2 dimer.  E.coli 
expressed and purified His-tagged Pba1-Pba2 dimer (see Fig. A.1.B) was loaded onto a Ni2+-
NTA sensor tip for the BLItz (ForteBio). The Blitz uses bio-layer interferometry to measure the 
association constant (ka) and dissociation constant (kd), which can be used to obtain the affinity 
constant KD (= kd/ka). The tip was transferred to an exchange buffer (150-175 seconds) to 
remove unbound protein. Next, tip is transferred to solution without or with increasing 
concentrations of CP (starting at 0.22 nM and doubling up to 1.8 μM). Analysis of the complete 
data set with baseline corrections yielded a KD of 1.2 μM (Ka = 8.6 ± 0.8 * 104 M-1s-1 and Kd 
0.10 ± 0.04 s-1). This KD is similar to data obtained by SPR 
1.  (B) Titrations of Pba1-Pba2 to 
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determine saturated binding on CP. CP from β2-YFP tagged strains was purified using an 
affinity-tag present on the β4 subunit. Next, purified CP was incubated with increasing amounts 
of His-tagged Pba1-Pba2 dimer for 30 minutes at 30 ºC. Samples were resolved on native gel 
and stained in gel for suc-LLVY-AMC (left panel) or analyzed for YFP signal using a Typhoon 
9410 imager (Middle panel). Gels were also transferred to membranes and immunoblotted for 
the presence of Pba1-Pba2 (right panel). At 5 fold molar excess maximum CP binding was 
observed. (D + E) Base fails to replace Pba1-Pba2 from immature CP. (D) Native gel analysis 
of mature and immature CP purified as prior. Samples were stained with suc-LLVY-AMC, 
showing proteolytic activity for mature CP, but not immature CP (left panel). Native gel was 
also transferred to pvdf membranes for immunoblotting. Middle panel shows immunoblot for 
Pba1-Pba2, indicating this dimer is absent from mature CP, but abundant on the immature CP. 
Right panel shows the α7 subunit of the proteasome. The mature CP sample has one major band, 
being mature CP with proteolytic activity (left panel), while immature CP shows two major 
species containing α7, one migrating close to mature CP, which lacks proteolytic activity but has 
Pba1-Pba2. The second faster migrating band is presumably an early assembly intermediate that 
still lacks the Pba1-Pba2 chaperones. (E) Samples from (d) were used in a reconstitution assay 
with the base (an RP subcomplex) in 10 fold molar excess. Reconstitution assays were resolved 
by native gel electrophoresis followed by in gel suc-LLVY-AMC activity assay or immunoblotting 
(α7 is a CP subunit and Rpt1 and base subunit subunit). Data show that the base reconstitutes 
efficiently on mature CP (lane 2), however, no reconstitution onto immature CP was observed 
(compare lane 2 with 4 and 5 in right panel). 
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Figure A.3 Supporting data related to Figure 3 Pba1-Pba2 prevents assembly deadlock. 
 
 
 
(A) Assembly yield is robust to variations in RP and CP concentration in the model. These 
results are from the mathematical model described in the main text and described in greater 
detail in the supplemental methods online.  Aside from variations in total RP and CP 
concentration ([RP]0 and [CP]0, respectively), all the parameters are identical to those used for 
the "Affinity Switch" model in the main text.  The concentration of the chaperone Pba1-Pba2 was 
held constant at 1 µM.  Since the CP and RP are at different concentrations in this case, the 
assembly yield is defined as the concentration of the RP-CP complex divided by the total 
concentration of RP or CP, depending on which is smaller.  We find that near 100% yield is 
obtained for a wide variety of concentrations of both RP and CP, indicating that the results in 
Figure 2.3 of the chapter 2 do not depend on a specific set of RP and CP concentrations. (B) 
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Changes in the magnitude of the affinity switch do not qualitatively effect our predictions. Left 
panel; this is an analogue of Figure 2.3A in the main text, but with an affinity switch that is 
smaller (100 times instead of 1,000 times).  In this model, the KD of Pba1-Pba2 for the immature 
CP is unchanged at 1 nM, but it binds more tightly to the mature CP (KD = 100 nM). Right 
panel; this is an analogue of Figure 2.3A in the main text, but with an affinity switch that is 
larger (10,000 times instead of 1,000 times).  The KD of the interaction with the immature CP is 
again unchanged at 1 nM, but the KD that in 
both cases, there is a broad range of Pba1-Pba2 concentration that provides near-100% 
assembly yields.  Modifying the affinity switch by making the KD to the immature form stronger 
(or weaker) give similar results (data not shown). 
 
Figure A.4 Supporting data related to Figure 4 Pba1-Pba2 are required for efficient 
incorporation of α5 and α6. 
 
  
 
(A) Immunoblot analysis of purified immature CP from strains containing an UMP1-TAP.  
2D-gelelectrophoresis of immature CP from a wildtype strain (see Fig. 2.4C main Chapter 2) 
was subjected to sequential immunoblotting. Panels show sequential probing of the membrane 
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for Pba1-Pba2 (top panel), β2 (middle panel) and finally α7 (lower panel). Spots indicated with 
an asterisk are signals derived from prior immunoblot, newly obtained signals are consistent 
with the expected PI and MW of proteins probed for. (B) Mass Spectrometry analysis of spots on 
2D gel. Indicated spots were excised and submitted for analysis by MALDI-TOF, spots for which 
no result was obtained were subsequent analyzed by LC-MS/MS. MALDI-TOF analyses each 
time identified only one protein with significant score (p<0.05). For LC-MS/MS only the 
identified proteins that contributed more than >20% to the total sample spectral count are 
reported to eliminate low abundant background contamination.  
Table 4.1 Mass spectrometry analysis of immature CP purified from Ump1-TAP tagged 
strain. 
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Appendix B - Supplementary information for chapter 3 
Figure B.1 Supporting data related to figure 3.4 Effect of α7 C-terminal truncation on 
Ecm29 expression level and its association to the proteasome. 
      
 
 
Equal amount of proteins from cell lysates of indicated strains were analyzed on the non-
denaturing gel. Type of proteasome complex formed is observed by in-gel activity assay by 
monitoring LLVY-AMC substrate degradation.  The gel is then subjected to the western blotting 
and immunoblotted with indicated antibodies. 
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Figure B.2 Supporting data related to figure 3.7 Phosphorylation at the C-terminal tail of 
the α7 is necessary for the Ecm29 interaction to the proteasome. 
 
(A) In addition to the α7-Δ19 (S/A), phosphomimic mutant was also created by replacing serine 
with aspartate α7-Δ19 (S/D). (B) Proteasome from the indicated strains were purified and equal 
amount of protein was analyzed on SDS-PAGE (upper panel). Amount of Ecm29 present on 
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proteasome complex and truncations of α7 in strains were confirmed by immunoblotting with 
respective antibodies. Ecm29 association with the proteasome was not affected in case of α7-Δ19 
(S/D) (C) Phosphomutants are confirmed by staining SDS-PAGE with Pro-Q-Diamond 
phosphostain.  α7-Δ19 that gets phosphorylated shows as faster migrating α7 band compared to 
wt. α7-Δ19(S/A) and α7-Δ19(S/D)mutants does not get phosphorylated hence no bands were 
observed after phosphostaining.  
 
 
 
 
 
